<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">41258</article-id><article-id pub-id-type="doi">10.7554/eLife.41258</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Murine HSCs contribute actively to native hematopoiesis but with reduced differentiation capacity upon aging</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-119609"><name><surname>Säwen</surname><given-names>Petter</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6854-1434</contrib-id><email>petter.sawen@med.lu.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121211"><name><surname>Eldeeb</surname><given-names>Mohamed</given-names></name><email>mohamed.eldeeb@med.lu.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121209"><name><surname>Erlandsson</surname><given-names>Eva</given-names></name><email>eva.erlandsson@med.lu.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121210"><name><surname>Kristiansen</surname><given-names>Trine A</given-names></name><email>trine.kristiansen@med.lu.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121212"><name><surname>Laterza</surname><given-names>Cecilia</given-names></name><email>cecilia.laterza@med.lu.se</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-81689"><name><surname>Kokaia</surname><given-names>Zaal</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2296-2449</contrib-id><email>zaal.kokaia@med.lu.se</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121213"><name><surname>Karlsson</surname><given-names>Göran</given-names></name><email>goran.karlsson@med.lu.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121214"><name><surname>Yuan</surname><given-names>Joan</given-names></name><email>joan.yuan@med.lu.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121215"><name><surname>Soneji</surname><given-names>Shamit</given-names></name><email>shamit.soneji@med.lu.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-121216"><name><surname>Mandal</surname><given-names>Pankaj K</given-names></name><email>Pankaj.Mandal@childrens.harvard.edu</email><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-3893"><name><surname>Rossi</surname><given-names>Derrick J</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-119611"><name><surname>Bryder</surname><given-names>David</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8761-4237</contrib-id><email>david.bryder@med.lu.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Division of Molecular Hematology, Department of Laboratory Medicine, Medical Faculty</institution><institution>Lund University</institution><addr-line><named-content content-type="city">Lund</named-content></addr-line><country>Sweden</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">StemTherapy</institution><institution>Lund University</institution><addr-line><named-content content-type="city">Lund</named-content></addr-line><country>Sweden</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Lund Stem Cell Center</institution><institution>Lund University</institution><addr-line><named-content content-type="city">Lund</named-content></addr-line><country>Sweden</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Department of Stem Cell and Regenerative Biology</institution><institution>Harvard University</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Program in Cellular and Molecular Medicine, Division of Hematology/Oncology</institution><institution>Boston Children’s Hospital</institution><addr-line><named-content content-type="city">Massachusetts</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Sahlgrenska Cancer Center</institution><institution>Gothenburg University</institution><addr-line><named-content content-type="city">Gothenburg</named-content></addr-line><country>Sweden</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Majeti</surname><given-names>Ravindra</given-names></name><role>Reviewing Editor</role><aff><institution>Stanford University</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Morrison</surname><given-names>Sean J</given-names></name><role>Senior Editor</role><aff><institution>Howard Hughes Medical Institute, University of Texas Southwestern Medical Center</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>18</day><month>12</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e41258</elocation-id><history><date date-type="received" iso-8601-date="2018-08-21"><day>21</day><month>08</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-11-28"><day>28</day><month>11</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Säwen et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Säwen et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-41258-v1.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.41258.001</object-id><p>A hallmark of adult hematopoiesis is the continuous replacement of blood cells with limited lifespans. While active hematopoietic stem cell (HSC) contribution to multilineage hematopoiesis is the foundation of clinical HSC transplantation, recent reports have questioned the physiological contribution of HSCs to normal/steady-state adult hematopoiesis. Here, we use inducible lineage tracing from genetically marked adult HSCs and reveal robust HSC-derived multilineage hematopoiesis. This commences via defined progenitor cells, but varies substantially in between different hematopoietic lineages. By contrast, adult HSC contribution to hematopoietic cells with proposed fetal origins is neglible. Finally, we establish that the HSC contribution to multilineage hematopoiesis declines with increasing age. Therefore, while HSCs are active contributors to native adult hematopoiesis, it appears that the numerical increase of HSCs is a physiologically relevant compensatory mechanism to account for their reduced differentiation capacity with age.</p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.41258.002</object-id><title>eLife digest</title><p>As far as we know, all adult blood cells derive from blood stem cells that are located in the bone marrow. These stem cells can produce red blood cells, white blood cells and platelets – the cells fragments that form blood clots to stop bleeding. They can also regenerate, producing more stem cells to support future blood cell production. But, our understanding of the system may be incomplete.</p><p>The easiest way to study blood cell production is to watch what happens after a bone marrow transplant. Before a transplant, powerful chemotherapy kills the existing stem cells. This forces the transplanted stem cells to restore the whole system from scratch, allowing scientists to study blood cell production in fine detail. But completely replacing the bone marrow puts major stress on the body, and this may alter the way that the stem cells behave. To understand how adult stem cells keep the blood ticking over on a day-to-day basis, experiments also need to look at healthy animals.</p><p>Säwén et al. now describe a method to follow bone marrow stem cells as they produce blood cells in adult mice. The technique, known as lineage tracing, leaves an indelible mark, a red glow, on the stem cells. The cells pass this mark on every time they divide, leaving a lasting trace in every blood cell that they produce. Tracking the red-glowing cells over time reveals which types of blood cells the stem cells make as well as provides estimates on the timing and extent of these processes.</p><p>It has previously been suggested that a few types of specialist blood cells, like brain-specific immune cells, originate from cells other than adult blood stem cells. As expected, the adult stem cells did not produce such cells. But, just as seen in transplant experiments, the stem cells were able to produce all the other major blood cell types. They made platelets at the fastest rate, followed by certain types of white blood cells and red blood cells. As the mice got older, the stem cells started to slow down, producing fewer blood cells each. To compensate, the number of stem cells increased, helping to keep blood cell numbers up.</p><p>This alternative approach to studying blood stem cells shows how the system behaves in a more natural environment. Away from the stresses of transplant, the technique revealed that blood stem cells are not immune to aging. In the future, understanding more about the system in its natural state could lead to ways to boost blood stem cells as we get older.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>hematopoiesis</kwd><kwd>stem cells</kwd><kwd>steady state</kwd><kwd>aging</kwd><kwd>lineage tracing</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002794</institution-id><institution>Cancerfonden</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Bryder</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004047</institution-id><institution>The Tobias foundation</institution></institution-wrap></funding-source><award-id>Tobias Prize</award-id><principal-award-recipient><name><surname>Bryder</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004359</institution-id><institution>Vetenskapsrådet</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Bryder</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004063</institution-id><institution>Knut och Alice Wallenbergs Stiftelse</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Bryder</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>ERC Consolidator grant (615068)</award-id><principal-award-recipient><name><surname>Bryder</surname><given-names>David</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Using a lineage tracing model, it is demonstrated that adult murine hematopoiesis is contingent on the continuous output from HSCs, with quantitative contributions that are dependent on lineage-type and age.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>HSC-derived hematopoiesis has usually been studied in the setting of transplantation (<xref ref-type="bibr" rid="bib8">Benz et al., 2012</xref>; <xref ref-type="bibr" rid="bib9">Biasco et al., 2016</xref>; <xref ref-type="bibr" rid="bib18">Dykstra et al., 2007</xref>; <xref ref-type="bibr" rid="bib30">Lu et al., 2011</xref>; <xref ref-type="bibr" rid="bib40">Rundberg Nilsson et al., 2015</xref>; <xref ref-type="bibr" rid="bib55">Wu et al., 2014</xref>), an experimental paradigm that has been the foundation of hematopoietic research for decades (<xref ref-type="bibr" rid="bib45">Siminovitch et al., 1963</xref>; <xref ref-type="bibr" rid="bib48">Till and McCulloch, 1961</xref>) and which has established hallmark properties of HSCs such as multi-potency and self-renewal. However, while the transplantation assay has provided key insights, not the least with relevance for the clinical use in bone marrow (BM) transplantation, it might not accurately reflect the contribution of HSCs to ongoing and unperturbed steady state hematopoiesis. This is because transplantation is conducted under highly non-physiological conditions wherein HSCs are forced to proliferate to rebuild an entire hematopoietic hierarchy in a myeloablated bone marrow micro-environment. Therefore, there is a need to approach HSC biology also in more unperturbed settings.</p><p>While the overall structure of hematopoiesis is rather well established (<xref ref-type="bibr" rid="bib11">Bryder et al., 2006</xref>), the degree by which HSCs contribute to adult hematopoiesis in the steady state is more unclear. This includes whether the proposed differentiation routes for the hematopoietic lineages are obligatory, or whether alternative/complementary pathways exist. Furthermore, cells of the different hematopoietic lineages have not only distinct homeostatic functions and maintenance mechanisms (<xref ref-type="bibr" rid="bib7">Bando and Colonna, 2016</xref>; <xref ref-type="bibr" rid="bib19">Dzierzak and Philipsen, 2013</xref>; <xref ref-type="bibr" rid="bib38">Rodvien and Mielke, 1976</xref>) but also display dramatically different lifespans (<xref ref-type="bibr" rid="bib20">Galli et al., 2011</xref>; <xref ref-type="bibr" rid="bib24">Harker et al., 2000</xref>; <xref ref-type="bibr" rid="bib50">Van Putten, 1958</xref>; <xref ref-type="bibr" rid="bib53">Westera et al., 2013</xref>). As a consequence, the rates by which separate adult-derived blood cell lineages must be replenished differ substantially. At the extreme end, certain hematopoietic cell types generated during the fetal period appear devoid of replenishment from adult progenitors, and rather rely on homeostatic proliferation for their maintenance (<xref ref-type="bibr" rid="bib22">Ginhoux and Guilliams, 2016</xref>; <xref ref-type="bibr" rid="bib27">Kantor et al., 1995</xref>).</p><p>Recent developments of transgenic mouse models that allow for identification (<xref ref-type="bibr" rid="bib1">Acar et al., 2015</xref>; <xref ref-type="bibr" rid="bib14">Chen et al., 2016</xref>; <xref ref-type="bibr" rid="bib21">Gazit et al., 2014</xref>) and evaluation of HSCs biology have facilitated studies of native in vivo hematopoiesis (<xref ref-type="bibr" rid="bib12">Busch et al., 2015</xref>; <xref ref-type="bibr" rid="bib42">Sawai et al., 2016</xref>; <xref ref-type="bibr" rid="bib47">Sun et al., 2014</xref>; <xref ref-type="bibr" rid="bib54">Wilson et al., 2008</xref>). Using one such model, we recently revealed that most adult HSCs are highly quiescent, which is strikingly different in the transplantation scenario (<xref ref-type="bibr" rid="bib43">Säwén et al., 2016</xref>). Other models have been used for lineage tracing from HSCs (<xref ref-type="bibr" rid="bib12">Busch et al., 2015</xref>; <xref ref-type="bibr" rid="bib42">Sawai et al., 2016</xref>; <xref ref-type="bibr" rid="bib47">Sun et al., 2014</xref>). In one of these, lineage tracing was conducted via random genetic integration of an inducible transposable genetic element, leading to the proposition that native hematopoiesis involves a large number of actively contributing progenitor cell clones, which are only rarely shared among hematopoietic lineages (<xref ref-type="bibr" rid="bib47">Sun et al., 2014</xref>). More common approaches for lineage tracing involve the use of cell type specific recombinases, that function to irreversibly mark a cell of interest and with time its descendants. While elegant and extensively used among developmental biologists, such approaches have only sparsely been applied to adult HSCs, and with seemingly contradictory results. Using a Tie2-driven model, Busch et al. concluded a substantial hematopoietic contribution/maintenance from progenitors rather than HSCs (<xref ref-type="bibr" rid="bib12">Busch et al., 2015</xref>), which at least to some extent would appear compatible with the results from <xref ref-type="bibr" rid="bib47">Sun et al. (2014)</xref>. By contrast, Sawai et al. utilized a Pdzk1ip1-based CreERT2 system and suggested robust HSC labeling and hematopoiesis from adult HSCs (<xref ref-type="bibr" rid="bib42">Sawai et al., 2016</xref>).</p><p>To try to assess these potential ambiguities, we here investigated the degree to which HSCs contribute to steady state adult hematopoiesis by using an inducible Fgd5-based HSC lineage tracing model (<xref ref-type="bibr" rid="bib21">Gazit et al., 2014</xref>). We observed dramatic differences with regards to HSC contribution to adaptive immunity (slow) and the myeloerythroid lineages (fast), with HSCs contributing to the platelet lineage with the most rapid kinetics. The regeneration of terminal cell fates was closely mirrored at the level of each intermediate myeloerythroid precursor. These findings are consistent with adult HSCs as highly active contributors to multilineage hematopoiesis not only following transplantation, but also during the steady state. However, when approached in the situation of chronological aging, we noted diminished mature blood cell output from aged HSCs that could be traced to the first differentiation events from HSCs. These results suggest that the previously proposed fetal to adult switch (<xref ref-type="bibr" rid="bib10">Bowie et al., 2007</xref>), in which HSCs alter their properties from more excessive proliferation/differatiation to a more dormant state in the adult, extends gradually throughout adulthood. As a consequence, the well-known numerical increase of HSCs with age (<xref ref-type="bibr" rid="bib32">Morrison et al., 1996</xref>; <xref ref-type="bibr" rid="bib39">Rossi et al., 2005</xref>; <xref ref-type="bibr" rid="bib46">Sudo et al., 2000</xref>) appears to represent a physiologically relevant mechanism to account for reduced HSC differentiation with age.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Fgd5-CreERT2-based lineage tracing allows for assessment of HSC contributions to unperturbed hematopoiesis</title><p>Using a transcriptome based screen of more than 40 different hematopoietic cell types, Fgd5 (FYVE, RhoGEF and PH domain containing 5) was identified as a HSC-expressed gene that is rapidly downregulated upon differentiation. That Fgd5 expression marks all HSCs was confirmed through functional studies using an Fgd5 knock-in reporter strain (<xref ref-type="bibr" rid="bib21">Gazit et al., 2014</xref>). To further detail the HSC specificity of Fgd5, we first acquired transcriptome data from 11,581 individual lineage-marker negative, c-kit positive and CD45 positive bone marrow cells (Lin<sup>-</sup>kit<sup>+</sup>). The Lin<sup>-</sup>kit<sup>+</sup> population contains a range of different immature hematopoietic progenitor cells (<xref ref-type="bibr" rid="bib37">Pronk et al., 2007</xref>). Therefore, Lin<sup>-</sup>kit<sup>+</sup> cells provided a benchmark to which other more defined/specific hematopoietic progenitor subsets could be compared. Next, we took advantage of an Fgd5 reporter strain in which a ZsGreen-2A-CreERT2 allele was knocked into the endogenous <italic>Fgd5</italic> locus (hereafter <italic>Fgd5<sup>CreERT2/+</sup></italic> mice) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) (<xref ref-type="bibr" rid="bib21">Gazit et al., 2014</xref>). We sorted either Lin<sup>-</sup>kit<sup>+</sup>Fgd5<sup>+</sup> cells (<xref ref-type="fig" rid="fig1">Figure 1A</xref> middle; 793 cells, Fgd5<sup>+</sup>), or Fgd5<sup>+</sup> cells with a stringent Lin<sup>-</sup>kit<sup>+</sup>Sca-1<sup>+</sup>CD48<sup>-</sup>CD150<sup>+</sup> HSC phenotype (<xref ref-type="fig" rid="fig1">Figure 1A</xref> right, 519 cells, HSC-Fgd5<sup>+</sup>). All Fgd5<sup>+</sup> and HSC-Fgd5<sup>+</sup> data were aggregated with the Lin<sup>-</sup>kit<sup>+</sup> transcriptome data, which was followed by identification of the most significant gene vectors using principal component analysis (PCA). Data was then visualized using t-distributed stochastic neighbor embedding (tSNE) dimensionality reduction (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Lin<sup>-</sup>kit<sup>+</sup> cells were extensively scattered across the two dimensions (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, left), in agreement with the heterogeneity of these cells. By contrast, Fgd5<sup>+</sup> cells, regardless if sorted based on additional HSC markers, formed a distinct and highly overlapping cluster (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, middle and right). This cluster localized to a region with very few cells when evaluating Lin<sup>-</sup>kit<sup>+</sup> cells (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, left, dotted area), emphasizing the HSC-specificity of the Fgd5 reporter and the low HSC frequency within the larger Lin<sup>-</sup>kit<sup>+</sup> fraction.</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.41258.003</object-id><label>Figure 1.</label><caption><title>Fgd5-CreERT2 specifically labels HSCs and Fgd5-mediated label progresses throughout the hematopoietic system.</title><p>(<bold>A</bold>) Lineage negative c-kit<sup>+</sup> cells (Lin<sup>-</sup>c-kit<sup>+</sup>, left), lineage negative c-kit<sup>+</sup> Fgd5<sup>+</sup> cells (Fgd5<sup>+</sup>, middle) and lineage negative Fgd5<sup>+</sup>c-kit<sup>+</sup>Sca-1<sup>+</sup>CD150<sup>+</sup>CD48<sup>-</sup> cells (HSC-Fgd5<sup>+</sup>, right) were isolated and subjected to single cell RNA-sequencing. The data was aggregated and visualized in a two-dimensional scatter plot after PCA and tSNE dimensionality reduction. Fgd5<sup>+</sup> cells are highlighted in pink (middle), Lin<sup>-</sup>c-kit<sup>+</sup> cells are highlighted in black (left plot) and HSC-Fgd5<sup>+</sup> cells are highlighted in blue (right plot). The area that Fgd5<sup>+</sup> cells occupy in relation to the transcriptomes of Lin<sup>-</sup>c-kit<sup>+</sup> cells and HSC-Fgd5<sup>+</sup> cells is marked by a dotted line (left and right plots). (<bold>B</bold>) Schematic representation of the <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> model. ZsGreen and CreERT2 are expressed from the Fgd5 locus and expression of a Tomato allele is driven by a CAG promoter from the Rosa26 locus and is preceded by a LoxP flanked STOP cassette. (<bold>C</bold>) Model description; HSCs selectively and continuously express ZsGreen in an Fgd5-dependent manner. Upon Tamoxifen (TAM) administration, HSCs express Tomato and expression of Tomato label is inherited by all progeny of Tomato-expressing HSCs. (<bold>D</bold>) Representative FACS plots showing Tomato label in BM HSPCs from <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice that were injected with Tamoxifen 48 hr prior to analysis. (D, lower right) Representative histograms depicting Tomato label in PB cells at various time points after the start of Tamoxifen administration from mice in <xref ref-type="fig" rid="fig3">Figure 3B</xref> (T cells 48 weeks, B cells 25 weeks, granulocytes and monocytes 8 weeks, platelets and erythrocytes 13 weeks). Numbers in FACS plots depict the mean % of Tomato labeled cells ± SD (n = 5) and dashed lines in histograms indicates the boundary for Tomato positivity. (<bold>E</bold>) FACS plots showing H2B-mCherry label retention and Tomato labeling in Lineage<sup>-</sup>c-kit<sup>+</sup>CD150<sup>+</sup>CD48<sup>-</sup> and Sca1<sup>+</sup> or Sca1<sup>-</sup> cells from a representative mouse that had diluted H2B-mCherry label for 5 weeks and were injected with Tamoxifen 5 days prior to analysis (n = 3; 14–19 weeks old at analysis). (<bold>F</bold>) The fraction of donor-derived cells among different blood cell lineages was assessed in individual mice 16 weeks post-transplantation in recipients of 5 Tomato<sup>+</sup> (n = 8) or 5 Tomato<sup>-</sup> (n = 7) HSCs. Abbreviations: 2A, 2A self-cleaving peptide; CAG, CAG promoter; loxP, LoxP site.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41258-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41258.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title>FACS gating strategies for identification of hematopoietic subsets.</title><p>(<bold>A</bold>) The gating scheme for identification of HSCs/MPPs and myeloerythroid progenitors within the LSK and LK populations, respectively. (<bold>B</bold>) The gating scheme for identification of peripheral blood subsets. Red histogram display Ter119 expression in erythrocytes over an unlabeled control (grey histogram) and platelets identified by gating on scatter characteristics display expression of both CD41 and CD150.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41258-fig1-figsupp1-v1.tif"/></fig></fig-group><p>We next generated a lineage tracing model by crossing <italic>Fgd5<sup>CreERT2/+</sup></italic> mice to <italic>Rosa26-Lox-Stop-Lox-Tomato</italic> mice (hereafter <italic>Rosa26<sup>lsl-Tomato/+</sup></italic>) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). In this model, HSCs can be identified based on ZsGreen expression, while Tamoxifen administration leads to irreversible and heritable Tomato labeling of HSCs and, over time, their offspring (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). To confirm the model, we evaluated Tomato label in HSC and BM progenitor cells 48 hr after a single injection (1x) of Tamoxifen. This revealed labeling of a fraction of candidate HSCs, with virtually no labeling in other c-kit<sup>+</sup> progenitor fractions (<xref ref-type="fig" rid="fig1">Figure 1D</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). This established HSC specific labeling and a relatively low differentiation rate of HSCs in steady state (<xref ref-type="bibr" rid="bib43">Säwén et al., 2016</xref>; <xref ref-type="bibr" rid="bib54">Wilson et al., 2008</xref>). To illustrate our ability to detect Tomato label in peripheral blood (PB) cells, we assessed Tomato expression in defined cell types from mice that had received Tamoxifen 8–48 weeks previously (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, lower right). Complementary to immunophenotypic identification of initially labeled BM cells as HSCs (<xref ref-type="fig" rid="fig1">Figure 1D</xref> and data not shown), we evaluated the proliferation history of Tomato labeled HSPCs 5 days after a pulse of Tomato labeling by evaluation of transgenic H2B-mCherry label retention (<xref ref-type="fig" rid="fig1">Figure 1E</xref>) (<xref ref-type="bibr" rid="bib43">Säwén et al., 2016</xref>). Among HSCs, this revealed a strong correlation between a restricted proliferative history and Tomato labeling. Of note, a single dose of Tamoxifen was insufficient to label all candidate Fgd5-expressing HSCs (<xref ref-type="fig" rid="fig1">Figure 1E</xref> and data not shown).</p><p>Finally, to corroborate that Tomato labeled phenotypic HSCs are bona fide HSCs, we injected mice with Tamoxifen and isolated candidate Tomato positive and negative HSCs 48 hr later. Sorted cells were transplanted at limiting dilution (5 cells/mouse). This revealed long-term multilineage reconstitution in 5/8 recipients transplanted with Tomato<sup>+</sup> HSCs (<xref ref-type="fig" rid="fig1">Figure 1F</xref>).</p></sec><sec id="s2-2"><title>Fgd5-lineage tracing reveals that HSCs generate different types of hematopoietic progeny with distinct kinetics</title><p>Encouraged by the highly specific HSC label observed after Tamoxifen administration to <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice (<xref ref-type="fig" rid="fig1">Figure 1</xref>), we next set out to perform label tracing studies of hematopoietic generation from HSCs. For this, we labeled cohorts of <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice with one injection of Tamoxifen and chased groups of mice for different periods of time up to 83 weeks after labeling. At end point analyses, the fraction of Tomato<sup>+</sup> cells was determined in various hematopoietic compartments to assess the HSC contribution to progenitor pools and mature blood cell subsets (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). The frequencies of Tomato<sup>+</sup> cells for each investigated subset were next related to the fraction of Tomato labeled HSCs (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, mean 13% ± 9%) in individual mice (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). The fraction of labeled HSCs was generally higher in mice analyzed beyond 4 days of chase compared to mice analyzed after shorter chase periods. However, no further increase in HSC labeling was noted after longer periods of chase (<xref ref-type="fig" rid="fig2">Figure 2A</xref>).</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.41258.005</object-id><label>Figure 2.</label><caption><title>Fgd5-CreERT2 mediated lineage tracing reveals robust HSC contribution with distinct kinetics into hematopoietic cell subsets in steady state and after transplantation.</title><p>Cohorts of <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice were chased for up to 83 weeks after receiving one Tamoxifen injection before endpoint analysis of the % of Tomato<sup>+</sup> cells in HSCs (<bold>A</bold>) and hematopoietic progenitor and PB cell subsets (<bold>B</bold>). The fraction of Tomato<sup>+</sup> cells in each indicated hematopoietic cell subset was divided by the % Tomato label in HSCs in corresponding mice to determine the ratio of Tomato<sup>+</sup> cells relative to HSCs in individual mice. The average ratio is plotted according to time after the Tamoxifen (TAM) injection and displayed in a heat map format. Mice were analyzed at 1–4 days (n = 18) and at 4 (n = 7), 8 (n = 8), 12 (n = 8), 16 (n = 4), 28 (n = 4), 32 (n = 5) and 83 (n = 3) weeks after the Tamoxifen injection. All mice were between 5 and 11 weeks old at the time of Tamoxifen injection. (<bold>C</bold>) PCA plot of multiplexed qRT-PCR data for 48 genes from triplicates of 10 cells from each of the indicated populations. Ellipses show an area where a new observation from the same group would position itself with a probability of 0.95. Numbers indicate the % of variance in the total data set that the respective PC explains. (<bold>D</bold>) For individual animals, the % of Tomato<sup>+</sup> cells in PB cell types was divided by the % of Tomato<sup>+</sup> cells in the indicated progenitor cell types and this value was plotted according to the duration of the chase period. Symbols represent individual mice (number of mice analyzed as in A and B). A dashed line is drawn to indicate an equilibrium-ratio of 1. (<bold>E</bold>) Ratios calculated as in B and plotted according to the number of weeks after transplantation or after the start of Tamoxifen administration for steady state/native mice (n = 3 for WBM tx in CD45 depleted, n = 5 for WBM tx in irradiated, n = 11 for HSC tx in irradiated, n = 4–8 for 1x TAM, n = 4–9 for continous TAM). All <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice/cells were between 5 and 11 weeks old at the time of Tamoxifen administration or when used as cell donors for transplantation.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41258-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41258.006</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Label induction and progression in 1x Tamoxifen treated adult <italic>Fgd5<sup>CreERT2/+</sup></italic>; <italic>Rosa26<sup>lsl-Tomato/+</sup></italic> mice.</title><p><italic>Left column</italic>: percentages of Tomato<sup>+</sup> cells among the indicated hematopoietic subsets in bone marrow and peripheral blood at the indicated time after a single Tamoxifen injection. <italic>Right column</italic>: ratio of the % of Tomato<sup>+</sup> cells in the indicated hematopoietic cell subsets relative to the % of Tomato<sup>+</sup> HSCs in corresponding mice. Mice were analyzed 24 hr (n = 6), 48 hr (n = 6), 96 hr (n = 6), 4 w (n = 7), 8 w (n = 8), 12 w (n = 8), 16 w (n = 4), 28 w (n = 4), 32 w (n = 5) and 83 w (n = 3) after Tamoxifen injection. Cohorts of mice were injected with Tamoxifen in five different experiments. Symbols indicate individual mice and bars indicate the mean Tomato level at each time point evaluated.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41258-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41258.007</object-id><label>Figure 2—figure supplement 2.</label><caption><title>In vitro differentiation potential of LSK HSPCs.</title><p>Single GMLPs (n = 279), HSCs (n = 240) and LSKCD150<sup>+</sup>CD48<sup>+</sup> cells (n = 460) were seeded into Terasaki wells and cultured for 6 days before scoring wells for erythroid cells and megakaryocytes by microscopic evaluation. The % of wells containing erythroid cells (red), megakaryocytes (orange) or cells other than erythroid or megakaryocytes (green) are plotted in filled bars from the different indicated cells evaluated.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41258-fig2-figsupp2-v1.tif"/></fig></fig-group><p>First, we investigated Tomato label progression into the immature lineage negative, Sca-1 positive and c-kit positive (LSK) compartment, fractionated further using the Slam markers CD48 and CD150 (<xref ref-type="bibr" rid="bib28">Kiel et al., 2005</xref>) (<xref ref-type="fig" rid="fig2">Figure 2B</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). We used this approach to identify HSCs (LSKCD150<sup>+</sup>CD48<sup>-</sup>) and different multipotent progenitor fractions (MPPs: LSKCD150<sup>-</sup>CD48<sup>-</sup>, MPP<sup>2</sup>: LSKCD150<sup>+</sup>CD48<sup>+</sup>, MPP<sup>3/4</sup>: LSKCD150<sup>-</sup>CD48<sup>+</sup>).</p><p>LSKCD150<sup>-</sup>CD48<sup>-</sup> MPPs are immature multipotent progenitors distinguished from HSCs by their limited self-renewal potential (<xref ref-type="bibr" rid="bib28">Kiel et al., 2005</xref>; <xref ref-type="bibr" rid="bib29">Kiel et al., 2008</xref>; <xref ref-type="bibr" rid="bib49">Ugale et al., 2014</xref>). Of the evaluated progenitor subsets in our work, this subset was generated from HSCs with the fastest kinetics, with near equilibrium to HSC label reached already by 4 weeks (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p><p>MPP<sup>2</sup> cells represent a rare subset of cells with more undefined lineage/developmental affiliations. This prompted us to first elucidate their developmental potential. First, we aimed to place these cells within a transcriptional framework established by other, more established, hematopoietic progenitors. For this, we obtained gene expression data from a panel of defined stem and progenitor cells and MPP<sup>2</sup> cells using a multiplexed qRT-PCR approach for 48 genes, selected to include cell surface markers, cell cycle regulators and transcription factors associated with hematopoiesis (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Visualization of this data using PCA revealed that MPP<sup>2</sup> cells clustered closely to Meg/E progenitors (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Consistent with a close association to the Meg/E lineages, short-term (6 days) culture experiments revealed a more robust generation of both megakaryocyte and erythroid containing colonies from MPP<sup>2</sup>s compared to other LSK subsets (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). When investigating Tomato label progression, MPP<sup>2</sup> cells reached label equilibrium with HSCs after 32 weeks in 1x injected mice (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p><p>MPP<sup>3/4</sup> cells lack, for the most part, Meg/E lineage potential (<xref ref-type="bibr" rid="bib2">Adolfsson et al., 2005</xref>; <xref ref-type="bibr" rid="bib5">Arinobu et al., 2007</xref>; <xref ref-type="bibr" rid="bib36">Pietras et al., 2015</xref>; <xref ref-type="bibr" rid="bib37">Pronk et al., 2007</xref>). MPP<sup>3/4</sup> cells acquired Tomato label with much slower kinetics compared to other LSK fractions (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p><p>Of the distinct progenitor fractions within the Lin<sup>-</sup>kit<sup>+</sup> fraction (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>), megakaryocyte progenitors (MkP) acquired label with the fastest kinetics, reaching label equilibrium with HSCs after 32 weeks. Other myeloerythroid progenitors, including pre-megakaryocytic/erythroid (preMeg/E), pre-colony forming unit-erythroid (pre CFU-E) and pre-granulocyte-macrophage (preGM) progenitors acquired Tomato label with very similar kinetics despite their distinct lineage affiliations, although they never quite reached an equilibrium with HSCs throughout the course of the experiments (<xref ref-type="fig" rid="fig2">Figure 2B</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>).</p><p>Mature effector cells represent the terminal progeny of HSCs. We observed distinct generation kinetics for different lineages (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). First, we made the general observation that myeloerythroid cells acquired label more rapidly than lymphoid cells. Among the myeloid subsets, platelets acquired Tomato label with the fastest kinetics, followed by granulocytes and erythrocytes. Among lymphoid cell types, NK cells displayed faster labeling kinetics followed by B cells. T cells showed the slowest labeling kinetics among lymphoid cells and CD4<sup>+</sup> T cells acquired label faster than CD8<sup>+</sup> T cells (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Because the frequency of Tomato<sup>+</sup> cells increased over time in all evaluated lineages, this data demonstrate a continuous contribution of HSCs to all hematopoietic lineages.</p><p>While multiple studies have defined populations of hematopoietic progenitors that associate with distinct developmental and/or stages of differentiation (<xref ref-type="bibr" rid="bib11">Bryder et al., 2006</xref>), it is unknown whether such described progenitors are obligatory intermediates and/or their quantitative association relative to their anticipated mature offspring. Therefore, we interrogated the relationships between the rates of (re)generation of candidate committed myeloerythroid progenitors to those of their proposed mature cell lineage. At the earliest time points evaluated, we observed for all evaluated fractions a higher label in their corresponding progenitors (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). However, this was resolved during the course of the experiments and reached similar equilibrium ratios for all evaluated lineages, although the erythroid lineage displayed somewhat slower kinetics (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Collectively, these experiments are in line with the view that progenitor generation precedes the generation of mature cells and that previously proposed progenitors appears to be, at least for the most part, obligatory intermediates.</p><p>Hematopoiesis after transplantation of HSCs is fundamentally different from unperturbed hematopoiesis (<xref ref-type="bibr" rid="bib12">Busch et al., 2015</xref>; <xref ref-type="bibr" rid="bib47">Sun et al., 2014</xref>). However, to what extent the pre-conditioning regimen and co-transplantation of mature cells and progenitors influence on hematopoiesis from HSCs is less established. Therefore, we next transplanted wild type recipient mice on continuous Tamoxifen diet with purified <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> HSCs or WBM cells. Here, recipient mice were pre-conditioned by either lethal irradiation or antibody mediated CD45-depletion (<xref ref-type="bibr" rid="bib34">Palchaudhuri et al., 2016</xref>). Due to the HSC specificity of the model, this approach allowed us to monitor the kinetics of the HSC contribution to all lineages after transplantation and compare it to the HSC contribution in steady state (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Compared to steady state, label progression in transplanted mice were faster (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). When label progression kinetics was compared between HSC and WBM transplanted animals, HSC transplantation resulted in faster label progression, especially into the B cell lineage (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). This likely reflects a significant contribution to the regeneration of the B cell lineage by co-transplanted long-lived B-lineage progenitors and mature cells after WBM transplantation. Comparison of label progression after WBM transplantation into irradiated or non-irradiated/antibody-mediated conditioned recipient mice revealed similar label progression kinetics into most mature lineages, with the exception of platelets that displayed a faster label progression in irradiated mice. This suggests that progenitors for platelets are more effectively ablated by irradiation than antibody-mediated pre-conditioning.</p></sec><sec id="s2-3"><title>Fgd5-mediated HSC lineage tracing corroborates the fetal/juvenile origin of Langerhans cells, B1a B cells and brain microglial cells</title><p>While a labeling regimen of one Tamoxifen injection allows for accurate kinetic evaluations (<xref ref-type="fig" rid="fig2">Figure 2A–B,D</xref>), this experimental strategy labels only a fraction of HSCs (<xref ref-type="fig" rid="fig1">Figure 1E</xref> and <xref ref-type="fig" rid="fig2">Figure 2A</xref>) and thus necessitates correlation of label in HSCs to other evaluated cell subsets (<xref ref-type="bibr" rid="bib12">Busch et al., 2015</xref>) (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). If the original HSC label is low, this might as a consequence not allow for evaluation of the activity of the entire pool of HSCs.</p><p>To explore whether we could label the HSC pool more extensively, <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice were fed Tamoxifen containing food pellets for 16 weeks. To rule out adverse effects of prolonged Tamoxifen treatment on HSC proliferation, these experiments were preceded by a control label retaining experiment using <italic>Col1a1<sup>tetO-H2B-mCherry/tetO-H2B-mCherry</sup>; ROSA26<sup>rtTA/rtT</sup></italic> mice (<xref ref-type="bibr" rid="bib43">Säwén et al., 2016</xref>). Following H2B-mCherry induction with Doxycycline, mice were chased for 5 weeks in the presence or absence of Tamoxifen. Prolonged Tamoxifen treatment did not induce any additional proliferation within the HSC compartment, while more differentiated progenitors had readily proliferated in both settings (<xref ref-type="fig" rid="fig3">Figure 3A</xref>).</p><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.41258.008</object-id><label>Figure 3.</label><caption><title>Fgd5-mediated lineage tracing after complete HSC labeling reveals limited adult HSCs contribution to tissue-resident immune cell subsets.</title><p>(<bold>A</bold>) H2B-mCherry label retention in HSCs and myeloid progenitors after 5 weeks of chase in mice continuously fed Tamoxifen (TAM) containing food (blue histograms, n = 7) or normal food (red histograms, n = 6) during the chase period. Green histograms depict an unlabeled control. Dashed lines indicate the boundary for H2B-mCherry positivity. Lineage negative c-kit<sup>+</sup>Sca1<sup>-</sup> cells are denoted as myeloid progenitors. (<bold>B</bold>) Cohorts of <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice were continuously fed Tamoxifen food for 16 weeks (TAM phase) and thereafter normal chow during a chase phase of 32 weeks (n = 5) or 41 weeks (n = 4). During the TAM and chase phases, PB was regularly analyzed for Tomato label in the indicated subsets. Data points indicate the average % of Tomato label in each indicated subset. (<bold>C–E</bold>) Endpoint analysis, after 41 weeks chase, in mice from <xref ref-type="fig" rid="fig3">Figure 3B</xref> (n = 3). (<bold>C</bold>) Representative FACS plots showing the gating strategy to identify HSCs in lineage negative BM cells (left, middle) and depiction of the Tomato label in HSCs (right, red histogram) compared to an unlabeled control (blue histogram). Dashed line indicates the boundary for Tomato positivity, arrows indicate the gating strategy. (<bold>D</bold>) Representative FACS plots of cells isolated from skin tissue (epidermis) or the peritoneal cavity. Histograms show Tomato label (bottom left and right) or ZsGreen label (bottom middle) in the indicated subsets. Dashed line indicate the boundary for Tomato positivity, arrows indicate the gating hierarchy, gates and corresponding histograms are color matched. (<bold>E</bold>) Representative confocal images of the brain. (Left) IBA1 positive cells (green) are not labeled with Tomato (red, middle) while blood vessels are labeled with Tomato (middle). (Right) Merged images display both IBA1 staining and Tomato label. Scale bar = 50 μm. Mice in B-E were 5–6 weeks old at the start of Tamoxifen administration.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41258-fig3-v1.tif"/></fig><p>The 16 weeks labeling period was followed by an extensive (up to 41 weeks) chase period, during which mice received normal chow (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). This labeling strategy resulted in labeling of virtually all candidate HSCs (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). The blood of labeled mice was analyzed regularly to determine the fraction of Tomato<sup>+</sup> cells in PB cell subsets (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Similar to after 1x Tamoxifen labeling, we observed robust label progression into all PB cell subsets, with similar kinetics in between different lineages (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). However, a more complete HSC labeling resulted in a somewhat faster and more robust label progression into all PB cell subsets compared to 1x Tamoxifen labeling (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). This was most evident for the lymphoid lineages, where the majority of PB cells had been generated from HSCs at the experiment end point upon prolonged Tamoxifen administration, whereas the ratio of labeled lymphocytes vs. labeled HSCs was low (&gt;0,5) even after 83 weeks of chase in 1x Tamoxifen labeled mice (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="fig" rid="fig2">Figure 2E</xref> and <xref ref-type="fig" rid="fig3">Figure 3B</xref>).</p><p>From endpoint mice in which the pool of HSCs was almost completely labeled (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), we next interrogated the skin epidermis for Tomato<sup>+</sup> contribution to granulocytes and Langerhans cells. Granulocytes were almost completely Tomato positive, while Langerhans cells were devoid of label (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, lower left), in line with the fetal origin and self-maintenance of the latter cells (<xref ref-type="bibr" rid="bib16">Collin and Milne, 2016</xref>). Next, we interrogated Tomato expression in Vγ3δ<sup>+</sup> T cells, an established fetal derived T cell subset (<xref ref-type="bibr" rid="bib25">Havran and Allison, 1990</xref>). To our surprise, this revealed robust Tomato labeling of Vγ3δ<sup>+</sup> T cells (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, lower left). However, closer examination revealed high expression of ZsGreen in these cells (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, lower middle). Therefore, rather than establishing adult contribution to this lineage, these experiments established Fgd5-CreERT2 transgene expression in Vγ3δ<sup>+</sup> T cells.</p><p>B1a B cells represent an invariant subtype of B cells with a fetal origin that is primarily located in the peritoneum (<xref ref-type="bibr" rid="bib26">Hayakawa et al., 1985</xref>), where they co-exists with more traditional B1b and B2 B cells in adult mice. While less than 10% of B1a B cells displayed Tomato label, around 50% of B1b B cells and the vast majority of B2 B cells (<xref ref-type="fig" rid="fig3">Figure 3D</xref> right) were Tomato<sup>+</sup> (comparable to levels in PB). This is in line with a more strict fetal/postnatal origin of B1a B cells, the ontogenically mixed origin of B1b B cells (<xref ref-type="bibr" rid="bib27">Kantor et al., 1995</xref>) and an adult HSC origin of most B2 B cells.</p><p>Finally, we investigated adult HSC contribution to microglial cells of the brain, a subset of central nervous system myeloid cells that has been proposed to arise entirely from embryonic precursor cells (<xref ref-type="bibr" rid="bib4">Alliot et al., 1999</xref>). Evaluations by confocal microscopy of the brain parenchyma revealed no detectable Tomato expression in IBA-1<sup>+</sup> microglia (<xref ref-type="fig" rid="fig3">Figure 3E</xref>), while Fgd5 expressing endothelial cells (<xref ref-type="bibr" rid="bib15">Cheng et al., 2012</xref>; <xref ref-type="bibr" rid="bib21">Gazit et al., 2014</xref>) displayed abundant Tomato expression (<xref ref-type="fig" rid="fig3">Figure 3E</xref> middle).</p></sec><sec id="s2-4"><title>Native hematopoiesis from HSCs declines with aging</title><p>We next set out to investigate how chronological aging influence on HSC contribution to hematopoiesis. To achieve rapid and robust labeling of HSCs, we labeled juvenile and aged <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice by injecting Tamoxifen for five consecutive days (5x). Labeling was followed by evaluation of the fraction of Tomato positive cells in HSC and MPP fractions of the BM LSK compartment one day after the last Tamoxifen injection.</p><p>In aged mice, the initial labeling was highly specific to HSCs, with only low levels of labeling in MPP<sup>2</sup> cells. In sharp contrast, a larger fraction of LSKCD150<sup>-</sup>CD48<sup>-</sup> MPPs were labeled in juvenile mice (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Next, we correlated how increasing age influences on the HSC generation of other LSK/MPP subsets. <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice between 6 and 96 weeks of age were labeled using a 5x Tamoxifen injection scheme, before evaluation of Tomato label in HSCs/MPP<sup>2-4</sup>21 days later. Ratios of the fraction of labeled MPPs vs. labeled HSCs in corresponding mice was calculated and plotted against mouse age at labeling (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). This established that label progression into all MPP subsets in aged mice was substantially lower when compared to young adult mice and further revealed that the HSC contribution to MPPs and MPP<sup>3/4</sup>s gradually declines with age towards very little replenishment of in particular MPP<sup>3/4</sup> in very old age (<xref ref-type="fig" rid="fig4">Figure 4B</xref>).</p><fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.41258.009</object-id><label>Figure 4.</label><caption><title>Fgd5 mediate lineage tracing reveals gradually declining HSC contribution to hematopoiesis with age.</title><p>(<bold>A</bold>) Cohorts of aged (11–12 months; n = 3) or young (23–25 days; n = 5,) <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice were injected with Tamoxifen 5 times on consecutive days and analyzed for Tomato label in LSK-HSPCs on day 6. Bars indicate median %. (<bold>B</bold>) <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice were injected with Tamoxifen for 5 consecutive days and analyzed for Tomato label in LSK-HSPCs 21 days later. The % of Tomato<sup>+</sup> cells in MPP<sup>2-4</sup> was divided by the % of Tomato<sup>+</sup> HSCs in corresponding mice to determine the ratio of Tomato<sup>+</sup> cells relative to HSCs. Ratios are plotted according to the age of mice at the time of Tamoxifen injection. (<bold>C</bold>) Indicated LSK subsets were isolated from <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice and transplanted into WT mice on continuous Tamoxifen. Multilineage hematopoiesis and Tomato contribution was assed in PB 4, 8, 12 and 16 weeks after transplantation. Values in parenthesis indicate the number of mice with Tomato<sup>+</sup> offspring. (<bold>D</bold>) Young (29 days; n = 3) and old (16 months; n = 4) <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice were injected once with Tamoxifen and analyzed for Tomato label 18 weeks later. The % of Tomato<sup>+</sup> cells in each indicated cell type was divided by the % of Tomato<sup>+</sup> HSCs in corresponding mice to determine the ratio of Tomato<sup>+</sup> cells relative to HSCs. (<bold>E</bold>) Model depicting HSC contribution to native hematopoiesis. Arrow weights and arrow lengths indicate the magnitude and the kinetics of HSC contribution to the indicated cell type respectively. The declining HSC contribution to hematopoiesis with age can be traced to a reduced differentiation of HSCs to MPPs (red arrows).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41258-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.41258.010</object-id><label>Figure 4—figure supplement 1.</label><caption><title>Aging associates with reduced multilineage HSC contribution.</title><p>The percentages of Tomato<sup>+</sup> cells among the indicated hematopoietic cells in bone marrow and peripheral blood 18 weeks following injection of Tamoxifen.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-41258-fig4-figsupp1-v1.tif"/></fig></fig-group><p>To evaluate the functional potential of initially Tomato-labeled MPPs, we FACS sorted HSCs and different MPP subsets isolated from non-labeled <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice and transplanted cells into lethally irradiated wild type mice. Recipient mice were provided Tamoxifen containing food pellets throughout the experiment. We analyzed donor chimerism and Tomato labeled PB cells after repetitive PB blood sampling. As expected, we did not observe any multilineage long-term reconstitution or Tomato<sup>+</sup> cells in MPP<sup>2</sup>/MPP<sup>3/4</sup> transplanted mice (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). 10 out of 10 HSC transplanted mice were multi lineage reconstituted at 16 weeks post transplantation with high levels of Tomato<sup>+</sup> donor cells in all evaluated lineages (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). More surprisingly 2 out of 9 MPP transplanted mice displayed donor reconstitution levels &gt; 1% in all lineages 16 weeks after transplantation (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). This long-term multilineage reconstitution potential from MPPs was accompanied with robust Tomato labeling among donor cells and revealed that Tomato labeled phenotypic MPPs perform as bona fide HSCs after transplantation (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). By contrast, mice that received MPP cells and displayed only transient myeloid reconstitution never displayed any Tomato<sup>+</sup> cells. This demonstrates, in young mice, the presence of a minor CD150<sup>-</sup> HSC activity that appears exclusively coupled to Fgd5 expression.</p><p>Finally, we were interested in determining whether the age-related decrease in HSC derived MPPs might influence on the generation kinetics of lineage-restricted progenitors and mature blood cells. For this, we labeled juvenile (29 days) and aged (87–89 weeks) <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice with 1x Tamoxifen, which was followed by evaluation of label progression after 18 weeks (<xref ref-type="fig" rid="fig4">Figure 4D</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). While the frequency of Tomato labeled HSCs was similar among the two groups (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>), all progeny exhibited reduced frequencies of Tomato labeled cells in aged mice, demonstrating a strikingly reduced multilineage differentiation capacity of HSCs as a consequence of age.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this work, we explored the cellular contribution from HSCs using a HSC-specific lineage tracing approach. Our work revealed robust HSC contribution to adult multilineage hematopoiesis and, while not focused at studying fetal hematopoiesis, support the previously reported fetal/juvenile origins of several other specific hematopoietic subsets. We observed the fastest label progression into the platelet lineage, which might be related to the recent observations that at least a subset of HSCs appears platelet-biased (<xref ref-type="bibr" rid="bib41">Sanjuan-Pla et al., 2013</xref>; <xref ref-type="bibr" rid="bib44">Shin et al., 2014</xref>). Thereafter, erythrocytes and granulocytes acquired label with similar kinetics, although Tomato<sup>+</sup> erythrocytes emerged in the peripheral blood somewhat later than granulocytes. This likely reflects the slower turnover of mature erythrocytes compared to other myeloid cells. On the other hand, among granulocytes, we did not find any noticeable differences when evaluating HSC contribution to the neutrophil or eosinophil lineages (data not shown), despite the seemingly distinct transcriptional underpinnings of these lineages (<xref ref-type="bibr" rid="bib17">Drissen et al., 2016</xref>).</p><p>Among lymphocytes, the HSC contribution was most rapid and robust to the NK cell lineage. At present, we can say little on whether this reflects an early and distinct progenitor intermediate for NK cells (<xref ref-type="bibr" rid="bib55">Wu et al., 2014</xref>) or whether NK cells are, at least partially, regenerated through myeloid progenitors (<xref ref-type="bibr" rid="bib13">Chen et al., 2015</xref>; <xref ref-type="bibr" rid="bib23">Grzywacz et al., 2011</xref>). While the extremely slow HSC generation of adaptive immune components (and T cells in particular) have implications for our understanding of HSCs, by proposing that adult HSCs to a large extent present as myeloid-biased in an unperturbed scenario, our results also suggest the necessity of very harsh conditioning to achieve an ‘immunological reboot’ (the generation of naïve lymphocytes) in certain autoimmune situations (<xref ref-type="bibr" rid="bib6">Atkins et al., 2016</xref>).</p><p>According to current models of hematopoiesis, lineage committed progenitors reside developmentally in between HSCs and their mature progeny, and much work has been aimed at detailing these stages (<xref ref-type="bibr" rid="bib2">Adolfsson et al., 2005</xref>; <xref ref-type="bibr" rid="bib3">Akashi et al., 2000</xref>; <xref ref-type="bibr" rid="bib5">Arinobu et al., 2007</xref>; <xref ref-type="bibr" rid="bib33">Oguro et al., 2013</xref>; <xref ref-type="bibr" rid="bib36">Pietras et al., 2015</xref>; <xref ref-type="bibr" rid="bib37">Pronk et al., 2007</xref>). What has remained more unknown is the relationships of these defined progenitors not only to HSCs and their mature offspring, but also whether they are obligatory. In our work, we could demonstrate that the generation rates of each evaluated myeloid progenitor subset correlated highly to their corresponding mature offspring, although the generation kinetics varied depending on lineage. Thus, although some challenges have recently been raised on how lineage commitment occur from HSCs based on inferences from large-scale single-cell RNA sequencing experiments (<xref ref-type="bibr" rid="bib35">Paul et al., 2015</xref>; <xref ref-type="bibr" rid="bib51">Velten et al., 2017</xref>), our data support the more conventional view that the generation of mature myeloid cells is preceded by the generation of obligatory lineage-committed intermediates.</p><p>Investigations of immature progenitors revealed that the most rapid label progression associated with LSKCD150<sup>-</sup>CD48<sup>-</sup> MPPs. MPPs share many defining properties of HSCs, including multilineage differentiation potential and very low proliferation rates in steady state (<xref ref-type="bibr" rid="bib43">Säwén et al., 2016</xref>). The distinction of MPPs from HSCs is mainly thought to result from pronounced differences in self-renewal; a property so far entirely evaluated by transplantation. Intriguingly, our work revealed that LSKCD150<sup>-</sup>CD48<sup>-</sup> MPPs displayed more rapid label kinetics in young mice, which was gradually declining with advancing age. At the same time, we could in agreement with previous studies (<xref ref-type="bibr" rid="bib52">Weksberg et al., 2008</xref>) also demonstrate a minor multilineage HSC activity in this compartment, which correlated exclusively to Fgd5 expression/Tomato labeling. Together with an overall decline in multilineage HSC contribution of aged mice, these results strongly propose a model in which aging associates with reduced/compromised HSC differentiation, which in combination with the well-established expansion of HSCs with age (<xref ref-type="bibr" rid="bib32">Morrison et al., 1996</xref>; <xref ref-type="bibr" rid="bib39">Rossi et al., 2005</xref>; <xref ref-type="bibr" rid="bib46">Sudo et al., 2000</xref>) appears to represent a physiologically relevant compensatory mechanisms to sustain multilineage hematopoiesis from HSCs (<xref ref-type="fig" rid="fig4">Figure 4E</xref>).</p><p>Compared to MPPs, MPP<sup>3/4</sup> are perhaps easier to approach given their restrictions in lineage potential (lack of Meg/E potential) (<xref ref-type="bibr" rid="bib2">Adolfsson et al., 2005</xref>; <xref ref-type="bibr" rid="bib5">Arinobu et al., 2007</xref>; <xref ref-type="bibr" rid="bib36">Pietras et al., 2015</xref>; <xref ref-type="bibr" rid="bib37">Pronk et al., 2007</xref>). We found MPP<sup>3/4</sup> to be regenerated from HSCs with slow kinetics compared to other downstream myeloid progenitor cells, but also to MPP<sup>2</sup> cells, that we in agreement with other studies (<xref ref-type="bibr" rid="bib36">Pietras et al., 2015</xref>) find ‘primed’ towards Meg/E development. Intriguingly, our data proposes a significant self-renewal activity of at least a subset of MPP<sup>3/4</sup>, with the demonstration that this fraction never reached label equilibrium with HSCs in any evaluated experimental setting. This might be particularly relevant in the setting of age, a situation in which HSC was found to generate MPP<sup>3/4</sup> very inefficiently (<xref ref-type="fig" rid="fig4">Figure 4E</xref>).</p><p>While limited, a few groups have recently approached HSC contribution to native hematopoiesis. Evaluations of hematopoiesis using transposon mobilization led to the conclusion that HSCs are not major contributors to adult hematopoiesis (<xref ref-type="bibr" rid="bib47">Sun et al., 2014</xref>). To some degree, this conclusion was later corroborated by CreER-mediated labeling of a minor fraction of the adult HSC pool using a Tie2-based CreER driver (<xref ref-type="bibr" rid="bib12">Busch et al., 2015</xref>). Limited HSC contribution to adult hematopoiesis is in sharp contrast to the results we present here and to results from another recent study (<xref ref-type="bibr" rid="bib42">Sawai et al., 2016</xref>). Our studies would propose that absence of a HSC specific driver, as in the work from Sun et al., makes interpretations of HSC contribution very complicated, not the least for the lymphoid lineages, while the labeling of only a minor fraction of HSCs, as in the work from Busch et al., might select for a subset of HSCs with a rather distinct functional behavior.</p><p>In summary, we conclude that although the study of native hematopoiesis highlights fundamental differences, with in particular slower regeneration times from HSCs to those seen after transplantation, they regardless corroborate decades of research derived from transplantation experiments in which HSCs has been proposed to continuously contribute to hematopoiesis.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) <break/>or resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Strain, strain <break/>background <break/>(M. musculus)</td><td><italic>Fgd5-CreERT2</italic></td><td>PMID:24958848</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:027789">IMSR_JAX:027789</ext-link></td><td/></tr><tr><td>Strain, strain <break/>background <break/>(M. musculus)</td><td><italic>Rosa26-rtTA;</italic> <break/><italic>Col1a1-tetO-</italic> <break/><italic>H2B-mCherry</italic> <break/></td><td>PMID:17554301</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:014602">IMSR_JAX:014602</ext-link></td><td/></tr><tr><td>Strain, strain <break/>background <break/>(M. musculus)</td><td><italic>Rosa26-</italic> <break/><italic>Lox-Stop-</italic> <break/><italic>Lox-Tomato</italic></td><td>PMID:20023653</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:007905">IMSR_JAX:007905</ext-link></td><td/></tr><tr><td rowspan="2">Antibody</td><td>B220 PECy5</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312994">AB_312994</ext-link></td><td rowspan="2">(1:400)</td></tr><tr><td>Clone: RA3-6B2</td></tr><tr><td rowspan="2">Antibody</td><td>B220 biotin</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312989">AB_312989</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: RA3-6B2</td></tr><tr><td rowspan="2">Antibody</td><td>B220 APC</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312997">AB_312997</ext-link></td><td rowspan="2">(1:400)</td></tr><tr><td>Clone: RA3-6B2</td></tr><tr><td rowspan="2">Antibody</td><td>CD105 PECy7</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1027700">AB_1027700</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: MJ7/18</td></tr><tr><td rowspan="2">Antibody</td><td>CD115 BV605</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2562760">AB_2562760</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: CSF-1R</td></tr><tr><td rowspan="2">Antibody</td><td>CD11b PECy5</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312793">AB_312793</ext-link></td><td rowspan="2">(1:400)</td></tr><tr><td>Clone: M1/70</td></tr><tr><td rowspan="2">Antibody</td><td>CD11b biotin</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312787">AB_312787</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: M1/70</td></tr><tr><td rowspan="2">Antibody</td><td>CD11b APC</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312795">AB_312795</ext-link></td><td rowspan="2">(1:800)</td></tr><tr><td>Clone: M1/70</td></tr><tr><td rowspan="2">Antibody</td><td>CD11b APC-Cy7</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_830641">AB_830641</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: M1/70</td></tr><tr><td rowspan="2">Antibody</td><td>CD11c BV570</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10900261">AB_10900261</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: N418</td></tr><tr><td rowspan="2">Antibody</td><td>CD150 APC</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_493460">AB_493460</ext-link></td><td rowspan="2">(1:400)</td></tr><tr><td>Clone: <break/>TC15-12F12.2</td></tr><tr><td rowspan="2">Antibody</td><td>CD150 PE</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313683">AB_313683</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: <break/>TC15-12F12.2</td></tr><tr><td rowspan="2">Antibody</td><td>CD16/32 AL700</td><td rowspan="2">eBioscience</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_493994">AB_493994</ext-link></td><td rowspan="2">(1:100)</td></tr><tr><td>Clone: 93</td></tr><tr><td rowspan="2">Antibody</td><td>CD19 PECy7</td><td rowspan="2">eBioscience</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_657663">AB_657663</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: 1D3</td></tr><tr><td rowspan="2">Antibody</td><td>CD19 BV-786</td><td rowspan="2">BD-Horizon</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2738141">AB_2738141</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: 1D3</td></tr><tr><td rowspan="2">Antibody</td><td>CD25 APC</td><td rowspan="2">eBioscience</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_469366">AB_469366</ext-link></td><td rowspan="2">(1:100)</td></tr><tr><td>Clone: PC 61.5</td></tr><tr><td rowspan="2">Antibody</td><td>CD31 PerCpCy5.5</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2566761">AB_2566761</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: MEC13.3</td></tr><tr><td rowspan="2">Antibody</td><td>CD3e PECy5</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312675">AB_312675</ext-link></td><td rowspan="2">(1:400)</td></tr><tr><td>Clone: <break/>145–2 C11</td></tr><tr><td rowspan="2">Antibody</td><td>CD3e biotin</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2563947">AB_2563947</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: 17A2</td></tr><tr><td rowspan="2">Antibody</td><td>CD3 AL700</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_493697">AB_493697</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: 17A2</td></tr><tr><td rowspan="2">Antibody</td><td>CD4 BV711</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2562607">AB_2562607</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: RM4-5</td></tr><tr><td rowspan="2">Antibody</td><td>CD4 APC eFl780</td><td rowspan="2">eBioscience</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1272219">AB_1272219</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: RM4-5</td></tr><tr><td rowspan="2">Antibody</td><td>CD41 PerCP-eFl710</td><td rowspan="2">eBioscience</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10855042">AB_10855042</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: MWReg30</td></tr><tr><td rowspan="2">Antibody</td><td>CD45.1 AL700</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_493733">AB_493733</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: A20</td></tr><tr><td rowspan="2">Antibody</td><td>CD45.2 PECy7</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1186098">AB_1186098</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: 104</td></tr><tr><td rowspan="2">Antibody</td><td>CD45.2 PE/ <break/>Dazzle</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2564177">AB_2564177</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: 104</td></tr><tr><td rowspan="2">Antibody</td><td>CD45.2 BV785</td><td rowspan="2">Sony</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2562604">AB_2562604</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: 104</td></tr><tr><td rowspan="2">Antibody</td><td>CD45.2 biotin</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313441">AB_313441</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: 104</td></tr><tr><td rowspan="2">Antibody</td><td>CD48 PECy7</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2075049">AB_2075049</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: <break/>HM48-1</td></tr><tr><td rowspan="2">Antibody</td><td>CD48 AL700</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10612755">AB_10612755</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: <break/>HM48-1</td></tr><tr><td rowspan="2">Antibody</td><td>CD5 BV-421</td><td rowspan="2">BD-Horizon</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2737758">AB_2737758</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: 53–7.3</td></tr><tr><td rowspan="2">Antibody</td><td>CD8 PerCpCy5.5</td><td rowspan="2">Sony</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2075239">AB_2075239</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: 53–6.7</td></tr><tr><td rowspan="2">Antibody</td><td>c-kit APCeFl780</td><td rowspan="2">eBioscience</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1272177">AB_1272177</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: 2B8</td></tr><tr><td rowspan="2">Antibody</td><td>c-kit APC</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313221">AB_313221</ext-link></td><td rowspan="2">(1:100)</td></tr><tr><td>Clone: 2B8</td></tr><tr><td rowspan="2">Antibody</td><td>F4/80 BV421</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_11203717">AB_11203717</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: BM8</td></tr><tr><td rowspan="2">Antibody</td><td>Flt3 biotin</td><td rowspan="2">eBioscience</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_466600">AB_466600</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: AZF10</td></tr><tr><td rowspan="2">Antibody</td><td>Gr1 PECy5</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313375">AB_313375</ext-link></td><td rowspan="2">(1:400)</td></tr><tr><td>Clone: RB6-8C5</td></tr><tr><td rowspan="2">Antibody</td><td>Gr1 FITC</td><td rowspan="2">BD PH</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394643">AB_394643</ext-link></td><td rowspan="2">(1:400)</td></tr><tr><td>Clone: RB6-8C5</td></tr><tr><td rowspan="2">Antibody</td><td>Gr1 biotin</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313369">AB_313369</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: RB6-8C5</td></tr><tr><td rowspan="2">Antibody</td><td>Gr1 BV711</td><td rowspan="2">Sony</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2562549">AB_2562549</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: RB6-8C5</td></tr><tr><td rowspan="2">Antibody</td><td>IL7Ra BV510</td><td rowspan="2">Sony</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2564576">AB_2564576</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: A7R34</td></tr><tr><td rowspan="2">Antibody</td><td>Ly6G APC/Fire750</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2616733">AB_2616733</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: 1A8</td></tr><tr><td rowspan="2">Antibody</td><td>NK1.1 PECy5</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_493591">AB_493591</ext-link></td><td rowspan="2">(1:400)</td></tr><tr><td>Clone: PK136</td></tr><tr><td rowspan="2">Antibody</td><td>NK1.1 Pacific Blue</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2132712">AB_2132712</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: PK136</td></tr><tr><td rowspan="2">Antibody</td><td>Sca1 Pacific Blue</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2143237">AB_2143237</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: E13-161.7</td></tr><tr><td rowspan="2">Antibody</td><td>TcR Vγ3 APC</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10895900">AB_10895900</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: 536</td></tr><tr><td rowspan="2">Antibody</td><td>TcR γ/δ BV605</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2563356">AB_2563356</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: GL3</td></tr><tr><td rowspan="2">Antibody</td><td>Ter119 PECy5</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313711">AB_313711</ext-link></td><td rowspan="2">(1:400)</td></tr><tr><td>Clone: Ter-119</td></tr><tr><td rowspan="2">Antibody</td><td>Ter119 biotin</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313705">AB_313705</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: Ter-119</td></tr><tr><td rowspan="2">Antibody</td><td>Ter119 PerCpCy5.5</td><td rowspan="2">Biolegend</td><td rowspan="2">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_893636">AB_893636</ext-link></td><td rowspan="2">(1:200)</td></tr><tr><td>Clone: Ter-119</td></tr><tr><td>Peptide, <break/>recombinant <break/>protein</td><td>Streptavidin <break/>BV605</td><td>Biolegend</td><td/><td>(1:400)</td></tr><tr><td>Peptide, <break/>recombinant <break/>protein</td><td>Streptavidin- <break/>Saporin</td><td>PMID: <break/>27272386 <break/>Advanced <break/>Targeting <break/>Systems</td><td/><td/></tr><tr><td>Chemical <break/>compound, <break/>drug</td><td>Tamoxifen</td><td>Sigma- <break/>Aldrich</td><td>I.p. 50 mg/kg</td><td/></tr><tr><td>Chemical <break/>compound, <break/>drug</td><td>Doxycycline</td><td>Ssniff <break/>Spezialdiäten</td><td>Food 2 g/kg</td><td/></tr><tr><td>Chemical <break/>compound, <break/>drug</td><td>Tamoxifen</td><td>Ssniff <break/>Spezialdiäten</td><td>Food <break/>400 mg/kg <break/>Tamoxifen <break/>Citrate</td><td/></tr><tr><td>Software, <break/>algorithm</td><td>Flowjo</td><td>FlowJo <break/>(<ext-link ext-link-type="uri" xlink:href="https://www.flowjo.com/solutions/flowjo">https://www.</ext-link> <break/><ext-link ext-link-type="uri" xlink:href="https://www.flowjo.com/solutions/flowjo">flowjo.com/solutions/flowjo</ext-link>)</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_008520">S</ext-link> <break/><ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_008520">CR_008520</ext-link></td><td/></tr><tr><td>Software, <break/>algorithm</td><td>Microsoft <break/>Excel</td><td>Microsoft <break/>Excel <break/>(<ext-link ext-link-type="uri" xlink:href="https://www.microsoft.com/en-gb/">https://www.microsoft.com/en-gb/</ext-link>)</td><td>RRID: <break/><ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_016137">SCR_016137</ext-link></td><td/></tr><tr><td>Software, <break/>algorithm</td><td>Graphpad <break/>Prism</td><td>GraphPad <break/>Prism (<ext-link ext-link-type="uri" xlink:href="https://graphpad.com">https://graphpad.com</ext-link>)</td><td>RRID: <break/><ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002798">SCR_002798</ext-link></td><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mouse procedures</title><p>For inducible marking of HSCs in vivo, we crossed <italic>Fgd5-2A-ZsGreen-CreERT2</italic> mice (<xref ref-type="bibr" rid="bib21">Gazit et al., 2014</xref>) (JAX 027789) to <italic>Rosa26-LoxP-Stop-LoxP-Tomato</italic> (<xref ref-type="bibr" rid="bib31">Madisen et al., 2010</xref>) (JAX 007905) mice, resulting in <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice. For simultaneous in vivo tracking of proliferation history and marking of HSCs, <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice were crossed with <italic>Col1a1<sup>tetO-H2B-mCherry/tetO-H2B-mCherry</sup>; ROSA26<sup>rtTA/rtTA</sup></italic> mice (JAX 014602) to generate <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/</sup></italic><sup>rtTA</sup>; <italic>Col1a1<sup>tetO-H2B-mCherry/+</sup></italic>. Such mice were administered doxycycline in food pellets (2 g/kg; Ssniff Spezialdiäten) for 2 weeks followed by 5 weeks of chase before HSC marking by a single i.p. Tamoxifen injection (50 mg/kg) and analysis 5 days later.</p><p>Tamoxifen was purchased from Sigma-Aldrich and suspended at 100 mg/ml in ethanol and mixed with sunflower oil to a concentration of 10 mg/ml. Tamoxifen was administered by intraperitoneal injections at 50 mg/kg body weight once (1x) or for 5 (5x) consecutive days. To acquire full/maximal HSC labeling, cohorts of mice were continuously fed Tamoxifen containing food pellets for 16 weeks. Mice on Tamoxifen food were regularly bled (sparsely; 1–2 drops) during the labeling period and during the chase period.</p><p>Transplanted recipient mice were subjected to lethal irradiation (950 rad) except CD45.1/2 mice that were CD45-depleted by intravenous injection of an immunotoxin (3 mg/kg) consisting of CD45.2-biotin (clone 104) and streptavidin-Saporin (Advanced Targeting Systems) in a 1:1 molar ratio 3 days prior to transplantation, as described (<xref ref-type="bibr" rid="bib34">Palchaudhuri et al., 2016</xref>). All transplanted cells were isolated from CD45.2 <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice. CD45-depleted recipients were transplanted with 10<sup>7</sup>whole bone marrow (WBM) cells and irradiated mice were transplanted with 3 × 10<sup>6</sup> WBM cells (n = 7), 200 (n = 10) or 100 (n = 2) HSCs, 635 MPPs (n = 10), 1200 MPP<sup>2</sup>s (n = 5) or 7300 MPP<sup>3/4</sup>s (n = 4). Tomato<sup>+</sup> and Tomato<sup>-</sup> HSCs were isolated from <italic>Fgd5<sup>CreERT2/+</sup>; Rosa26<sup>lsl-Tomato/+</sup></italic> mice injected with Tamoxifen 2 days before isolation and transplantation into congenic C57BL/6 (CD45.1<sup>+</sup>) mice on normal chow. Before transplantations of HSCs or MPPs FACS sorted cells were mixed with 3 × 10<sup>5</sup> WBM competitor cells in 200 µl PBS supplemented with 2 mM EDTA and 2% FBS before injection. Where indicated, recipient mice were given Tamoxifen containing food pellets (400 mg/kg Tamoxifen Citrate, Ssniff Spezialdiäten) throughout the experiments. At the indicated time point, PB was collected from the tail vein for reconstitution analysis.</p><p>H2B-mCherry labeling in <italic>Col1a1<sup>tetO-H2B-mCherry/tetO-H2B-mCherry</sup>; ROSA26<sup>rtTA/rtTA</sup></italic> mice was induced by administration of doxycycline (<xref ref-type="bibr" rid="bib43">Säwén et al., 2016</xref>). Thereafter, mice were chased for 5 weeks while eating Tamoxifen containing food pellets or normal chow (No TAM), followed by FACS analysis to assess H2B-mCherry dilution in HSCs/progenitors.</p><p>All mice were maintained at the animal facilities at BMC at Lund University and all experiments were performed with consent from the Malmö/Lund animal ethics board, reference number M186-15.</p></sec><sec id="s4-2"><title>Immunophenotyping and FACS</title><p>Immunophenotyping by FACS was done as described (<xref ref-type="bibr" rid="bib43">Säwén et al., 2016</xref>) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). For platelet and erythrocyte analysis, 1 μl of whole blood was taken to 300 μl PBS before FACS analysis. Cells were sorted and/or analyzed on a FACS Aria III cell sorter (Becton Dickinson) or on a LSRFortessa (Becton Dickinson).</p></sec><sec id="s4-3"><title>B1a, Langerhans cells and Vg3<sup>+</sup> T cell analysis</title><p>For isolation of peritoneal cells, peritoneal lavage was performed using 10 mL PBS. For isolation of skin epidermal cells, the flank of the mouse was shaved before excision of skin. The skin was incubated for 25 min at 37°C in a dissociation buffer (PBS containing 2.4 mg/ml of dispase (Roche) and 3% FCS) before separation of dermis from the epidermis. Pieces of epidermis were incubated for 30 min at 37°C in digestion buffer (PBS supplemented with 1 mg/ml collagenase IV [Sigma-Aldrich], 100 U/ml DNase I [Sigma], 2.4 mg/ml dispase [Roche] and 3% FBS) and thereafter filtered and stained against indicated markers. Before analysis, cells were incubated with Propidium Iodide (Invitrogen) to exclude dead cells.</p></sec><sec id="s4-4"><title>Immunohistochemistry</title><p>Mice were deeply anaesthetized with an overdose of pentobarbital and transcardially perfused with cold saline. Brains were post-fixed for 48 hr in 4% paraformaldehyde (PFA) and incubated in 20% sucrose for 24 hr before being cut in 30 μm thick coronal sections on a microtome. Sections were incubated in blocking solution (5% normal serum and 0.25% Triton X-100 in 0.1 M potassium-phosphate buffered solution) for one hour and subsequently overnight at 4°C with the primary antibody (Iba1 1:1000 Wako). Fluorophore-conjugated secondary antibody (Molecular Probes or Jackson Laboratories) was diluted in blocking solution and applied for 2 hr at room temperature. Tomato label could be detected without any staining. Nuclei were stained with Hoechst (Molecular Probes) for 10 min and sections were mounted with Dabco mounting medium. Images were obtained using confocal microscopy (Zeiss, Germany).</p></sec><sec id="s4-5"><title>Cell culture</title><p>Single LSKCD150<sup>+</sup>CD48<sup>+</sup> cells, MPP<sup>3/4</sup>s and HSCs were sorted into Terasaki wells containing 20 μl of media (OptiMEM supplemented with 10% FCS, 1:1000 Gentamicin (Invitrogen), 1:100 GlutaMAX (Invitrogen) and 1:500 β-mercaptoethanol (Invitrogen) supplemented with cytokines (mSCF (Peprotech) 100 ng/ml, TPO (Peprotech) 10 ng/ml, IL-3 (Peprotech) 5 ng/ml, EPO (Janssen) 5units/ml, human G-CSF (Amgen) 10 ng/ml). After 6 days of culture at 37°C, wells were scored and evaluated for the presence of megakaryocytes and erythroid cells by visual inspection in microscope.</p></sec><sec id="s4-6"><title>Gene expression analyses</title><p>qRT-PCR analyses using the Fluidigm Biomark HD Platform was done as described (<xref ref-type="bibr" rid="bib43">Säwén et al., 2016</xref>) (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). PCA on gene expression data from all reference populations was performed using Clustvis, (<ext-link ext-link-type="uri" xlink:href="http://biit.cs.ut.ee/clustvis/">http://biit.cs.ut.ee/clustvis/</ext-link>).</p><p>Single-cell RNA seq libraries were generated using a Chromium system (10x Genomics) according to the manufacturer’s instructions. Two consecutive sequencing runs were performed to achieve enough sequencing depth and data was combined and further analyzed using the Cell Ranger<sup>TM</sup> pipeline (10x Genomics). The accession number for the single-cell RNA sequencing data reported in this paper is GSE122473.</p></sec><sec id="s4-7"><title>Statistical analysis</title><p>Data were analyzed using Microsoft Excel (Microsoft) and Graphpad Prism (GraphPad Software). All FACS analyses were performed using Flowjo software (TreeStar).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgments</title><p>We thank Gerd Sten for expert technical support and Martin Wahlestedt for assistance with manuscript editing. The work was aided by the access to the StemTherapy funded core facilities in Bioinformatics and flow cytometry. This work was supported by grants from the Tobias Foundation, the Swedish Cancer Society, the Swedish Medical Research Council, the Knut and Alice Wallenberg foundation and an ERC Consolidator grant (615068) to DB.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation</p></fn><fn fn-type="con" id="con3"><p>Methodology</p></fn><fn fn-type="con" id="con4"><p>Methodology</p></fn><fn fn-type="con" id="con5"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Methodology</p></fn><fn fn-type="con" id="con7"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con8"><p>Methodology</p></fn><fn fn-type="con" id="con9"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con10"><p>Resources</p></fn><fn fn-type="con" id="con11"><p>Resources</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Visualization, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All mice were maintained at the animal facilities at BMC at Lund University, and were performed with consent from a local ethical committee reference number M186-15</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><object-id pub-id-type="doi">10.7554/eLife.41258.011</object-id><label>Supplementary file 1.</label><caption><title>Definitions of cells used throughout study.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-41258-supp1-v1.xlsx"/></supplementary-material><supplementary-material id="supp2"><object-id pub-id-type="doi">10.7554/eLife.41258.012</object-id><label>Supplementary file 2.</label><caption><title>List of analyzed genes in mutiplexed qRT-PCR gene expression analyses (<xref ref-type="fig" rid="fig2">Figure 2C</xref>).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-41258-supp2-v1.xlsx"/></supplementary-material><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.41258.013</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-41258-transrepform-v1.docx"/></supplementary-material><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession code GSE122473.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Säwén</surname><given-names>P</given-names></name><name><surname>Erlandsson</surname><given-names>E</given-names></name><name><surname>Soneji</surname><given-names>S</given-names></name><name><surname>Bryder</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>HSCs contribute actively to native multilineage hematopoiesis but with reduced differentiation capacity upon aging</data-title><source>Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE122473">GSE122473</pub-id></element-citation></p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acar</surname> <given-names>M</given-names></name><name><surname>Kocherlakota</surname> <given-names>KS</given-names></name><name><surname>Murphy</surname> <given-names>MM</given-names></name><name><surname>Peyer</surname> <given-names>JG</given-names></name><name><surname>Oguro</surname> <given-names>H</given-names></name><name><surname>Inra</surname> <given-names>CN</given-names></name><name><surname>Jaiyeola</surname> <given-names>C</given-names></name><name><surname>Zhao</surname> <given-names>Z</given-names></name><name><surname>Luby-Phelps</surname> <given-names>K</given-names></name><name><surname>Morrison</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal</article-title><source>Nature</source><volume>526</volume><fpage>126</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1038/nature15250</pub-id><pub-id pub-id-type="pmid">26416744</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adolfsson</surname> <given-names>J</given-names></name><name><surname>Månsson</surname> <given-names>R</given-names></name><name><surname>Buza-Vidas</surname> <given-names>N</given-names></name><name><surname>Hultquist</surname> <given-names>A</given-names></name><name><surname>Liuba</surname> <given-names>K</given-names></name><name><surname>Jensen</surname> <given-names>CT</given-names></name><name><surname>Bryder</surname> <given-names>D</given-names></name><name><surname>Yang</surname> <given-names>L</given-names></name><name><surname>Borge</surname> <given-names>OJ</given-names></name><name><surname>Thoren</surname> <given-names>LA</given-names></name><name><surname>Anderson</surname> <given-names>K</given-names></name><name><surname>Sitnicka</surname> <given-names>E</given-names></name><name><surname>Sasaki</surname> <given-names>Y</given-names></name><name><surname>Sigvardsson</surname> <given-names>M</given-names></name><name><surname>Jacobsen</surname> <given-names>SE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment</article-title><source>Cell</source><volume>121</volume><fpage>295</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.02.013</pub-id><pub-id pub-id-type="pmid">15851035</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akashi</surname> <given-names>K</given-names></name><name><surname>Traver</surname> <given-names>D</given-names></name><name><surname>Miyamoto</surname> <given-names>T</given-names></name><name><surname>Weissman</surname> <given-names>IL</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>A clonogenic common myeloid progenitor that gives rise to all myeloid lineages</article-title><source>Nature</source><volume>404</volume><fpage>193</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1038/35004599</pub-id><pub-id pub-id-type="pmid">10724173</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alliot</surname> <given-names>F</given-names></name><name><surname>Godin</surname> <given-names>I</given-names></name><name><surname>Pessac</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain</article-title><source>Developmental Brain Research</source><volume>117</volume><fpage>145</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/S0165-3806(99)00113-3</pub-id><pub-id pub-id-type="pmid">10567732</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arinobu</surname> <given-names>Y</given-names></name><name><surname>Mizuno</surname> <given-names>S</given-names></name><name><surname>Chong</surname> <given-names>Y</given-names></name><name><surname>Shigematsu</surname> <given-names>H</given-names></name><name><surname>Iino</surname> <given-names>T</given-names></name><name><surname>Iwasaki</surname> <given-names>H</given-names></name><name><surname>Graf</surname> <given-names>T</given-names></name><name><surname>Mayfield</surname> <given-names>R</given-names></name><name><surname>Chan</surname> <given-names>S</given-names></name><name><surname>Kastner</surname> <given-names>P</given-names></name><name><surname>Akashi</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages</article-title><source>Cell Stem Cell</source><volume>1</volume><fpage>416</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2007.07.004</pub-id><pub-id pub-id-type="pmid">18371378</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atkins</surname> <given-names>HL</given-names></name><name><surname>Bowman</surname> <given-names>M</given-names></name><name><surname>Allan</surname> <given-names>D</given-names></name><name><surname>Anstee</surname> <given-names>G</given-names></name><name><surname>Arnold</surname> <given-names>DL</given-names></name><name><surname>Bar-Or</surname> <given-names>A</given-names></name><name><surname>Bence-Bruckler</surname> <given-names>I</given-names></name><name><surname>Birch</surname> <given-names>P</given-names></name><name><surname>Bredeson</surname> <given-names>C</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Fergusson</surname> <given-names>D</given-names></name><name><surname>Halpenny</surname> <given-names>M</given-names></name><name><surname>Hamelin</surname> <given-names>L</given-names></name><name><surname>Huebsch</surname> <given-names>L</given-names></name><name><surname>Hutton</surname> <given-names>B</given-names></name><name><surname>Laneuville</surname> <given-names>P</given-names></name><name><surname>Lapierre</surname> <given-names>Y</given-names></name><name><surname>Lee</surname> <given-names>H</given-names></name><name><surname>Martin</surname> <given-names>L</given-names></name><name><surname>McDiarmid</surname> <given-names>S</given-names></name><name><surname>O'Connor</surname> <given-names>P</given-names></name><name><surname>Ramsay</surname> <given-names>T</given-names></name><name><surname>Sabloff</surname> <given-names>M</given-names></name><name><surname>Walker</surname> <given-names>L</given-names></name><name><surname>Freedman</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial</article-title><source>The Lancet</source><volume>388</volume><fpage>576</fpage><lpage>585</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)30169-6</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bando</surname> <given-names>JK</given-names></name><name><surname>Colonna</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Innate lymphoid cell function in the context of adaptive immunity</article-title><source>Nature Immunology</source><volume>17</volume><fpage>783</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1038/ni.3484</pub-id><pub-id pub-id-type="pmid">27328008</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benz</surname> <given-names>C</given-names></name><name><surname>Copley</surname> <given-names>MR</given-names></name><name><surname>Kent</surname> <given-names>DG</given-names></name><name><surname>Wohrer</surname> <given-names>S</given-names></name><name><surname>Cortes</surname> <given-names>A</given-names></name><name><surname>Aghaeepour</surname> <given-names>N</given-names></name><name><surname>Ma</surname> <given-names>E</given-names></name><name><surname>Mader</surname> <given-names>H</given-names></name><name><surname>Rowe</surname> <given-names>K</given-names></name><name><surname>Day</surname> <given-names>C</given-names></name><name><surname>Treloar</surname> <given-names>D</given-names></name><name><surname>Brinkman</surname> <given-names>RR</given-names></name><name><surname>Eaves</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs</article-title><source>Cell Stem Cell</source><volume>10</volume><fpage>273</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2012.02.007</pub-id><pub-id pub-id-type="pmid">22385655</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biasco</surname> <given-names>L</given-names></name><name><surname>Pellin</surname> <given-names>D</given-names></name><name><surname>Scala</surname> <given-names>S</given-names></name><name><surname>Dionisio</surname> <given-names>F</given-names></name><name><surname>Basso-Ricci</surname> <given-names>L</given-names></name><name><surname>Leonardelli</surname> <given-names>L</given-names></name><name><surname>Scaramuzza</surname> <given-names>S</given-names></name><name><surname>Baricordi</surname> <given-names>C</given-names></name><name><surname>Ferrua</surname> <given-names>F</given-names></name><name><surname>Cicalese</surname> <given-names>MP</given-names></name><name><surname>Giannelli</surname> <given-names>S</given-names></name><name><surname>Neduva</surname> <given-names>V</given-names></name><name><surname>Dow</surname> <given-names>DJ</given-names></name><name><surname>Schmidt</surname> <given-names>M</given-names></name><name><surname>Von Kalle</surname> <given-names>C</given-names></name><name><surname>Roncarolo</surname> <given-names>MG</given-names></name><name><surname>Ciceri</surname> <given-names>F</given-names></name><name><surname>Vicard</surname> <given-names>P</given-names></name><name><surname>Wit</surname> <given-names>E</given-names></name><name><surname>Di Serio</surname> <given-names>C</given-names></name><name><surname>Naldini</surname> <given-names>L</given-names></name><name><surname>Aiuti</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>In Vivo tracking of human hematopoiesis reveals patterns of clonal dynamics during early and steady-state reconstitution phases</article-title><source>Cell Stem Cell</source><volume>19</volume><fpage>107</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2016.04.016</pub-id><pub-id pub-id-type="pmid">27237736</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowie</surname> <given-names>MB</given-names></name><name><surname>Kent</surname> <given-names>DG</given-names></name><name><surname>Dykstra</surname> <given-names>B</given-names></name><name><surname>McKnight</surname> <given-names>KD</given-names></name><name><surname>McCaffrey</surname> <given-names>L</given-names></name><name><surname>Hoodless</surname> <given-names>PA</given-names></name><name><surname>Eaves</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Identification of a new intrinsically timed developmental checkpoint that reprograms key hematopoietic stem cell properties</article-title><source>PNAS</source><volume>104</volume><fpage>5878</fpage><lpage>5882</lpage><pub-id pub-id-type="doi">10.1073/pnas.0700460104</pub-id><pub-id pub-id-type="pmid">17379664</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryder</surname> <given-names>D</given-names></name><name><surname>Rossi</surname> <given-names>DJ</given-names></name><name><surname>Weissman</surname> <given-names>IL</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Hematopoietic stem cells: the paradigmatic tissue-specific stem cell</article-title><source>The American Journal of Pathology</source><volume>169</volume><fpage>338</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2006.060312</pub-id><pub-id pub-id-type="pmid">16877336</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busch</surname> <given-names>K</given-names></name><name><surname>Klapproth</surname> <given-names>K</given-names></name><name><surname>Barile</surname> <given-names>M</given-names></name><name><surname>Flossdorf</surname> <given-names>M</given-names></name><name><surname>Holland-Letz</surname> <given-names>T</given-names></name><name><surname>Schlenner</surname> <given-names>SM</given-names></name><name><surname>Reth</surname> <given-names>M</given-names></name><name><surname>Höfer</surname> <given-names>T</given-names></name><name><surname>Rodewald</surname> <given-names>HR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fundamental properties of unperturbed haematopoiesis from stem cells in vivo</article-title><source>Nature</source><volume>518</volume><fpage>542</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1038/nature14242</pub-id><pub-id pub-id-type="pmid">25686605</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Q</given-names></name><name><surname>Ye</surname> <given-names>W</given-names></name><name><surname>Jian Tan</surname> <given-names>W</given-names></name><name><surname>Mei Yong</surname> <given-names>KS</given-names></name><name><surname>Liu</surname> <given-names>M</given-names></name><name><surname>Qi Tan</surname> <given-names>S</given-names></name><name><surname>Loh</surname> <given-names>E</given-names></name><name><surname>Te Chang</surname> <given-names>K</given-names></name><name><surname>Chye Tan</surname> <given-names>T</given-names></name><name><surname>Preiser</surname> <given-names>PR</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Delineation of natural killer cell differentiation from myeloid progenitors in human</article-title><source>Scientific Reports</source><volume>5</volume><elocation-id>15118</elocation-id><pub-id pub-id-type="doi">10.1038/srep15118</pub-id><pub-id pub-id-type="pmid">26456148</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>JY</given-names></name><name><surname>Miyanishi</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>SK</given-names></name><name><surname>Yamazaki</surname> <given-names>S</given-names></name><name><surname>Sinha</surname> <given-names>R</given-names></name><name><surname>Kao</surname> <given-names>KS</given-names></name><name><surname>Seita</surname> <given-names>J</given-names></name><name><surname>Sahoo</surname> <given-names>D</given-names></name><name><surname>Nakauchi</surname> <given-names>H</given-names></name><name><surname>Weissman</surname> <given-names>IL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hoxb5 marks long-term haematopoietic stem cells and reveals a homogenous perivascular niche</article-title><source>Nature</source><volume>530</volume><fpage>223</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1038/nature16943</pub-id><pub-id pub-id-type="pmid">26863982</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>C</given-names></name><name><surname>Haasdijk</surname> <given-names>R</given-names></name><name><surname>Tempel</surname> <given-names>D</given-names></name><name><surname>van de Kamp</surname> <given-names>EH</given-names></name><name><surname>Herpers</surname> <given-names>R</given-names></name><name><surname>Bos</surname> <given-names>F</given-names></name><name><surname>Den Dekker</surname> <given-names>WK</given-names></name><name><surname>Blonden</surname> <given-names>LA</given-names></name><name><surname>de Jong</surname> <given-names>R</given-names></name><name><surname>Bürgisser</surname> <given-names>PE</given-names></name><name><surname>Chrifi</surname> <given-names>I</given-names></name><name><surname>Biessen</surname> <given-names>EA</given-names></name><name><surname>Dimmeler</surname> <given-names>S</given-names></name><name><surname>Schulte-Merker</surname> <given-names>S</given-names></name><name><surname>Duckers</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Endothelial cell-specific FGD5 involvement in vascular pruning defines neovessel fate in mice</article-title><source>Circulation</source><volume>125</volume><fpage>3142</fpage><lpage>3159</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.064030</pub-id><pub-id pub-id-type="pmid">22661514</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collin</surname> <given-names>M</given-names></name><name><surname>Milne</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Langerhans cell origin and regulation</article-title><source>Current Opinion in Hematology</source><volume>23</volume><fpage>28</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1097/MOH.0000000000000202</pub-id><pub-id pub-id-type="pmid">26554892</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drissen</surname> <given-names>R</given-names></name><name><surname>Buza-Vidas</surname> <given-names>N</given-names></name><name><surname>Woll</surname> <given-names>P</given-names></name><name><surname>Thongjuea</surname> <given-names>S</given-names></name><name><surname>Gambardella</surname> <given-names>A</given-names></name><name><surname>Giustacchini</surname> <given-names>A</given-names></name><name><surname>Mancini</surname> <given-names>E</given-names></name><name><surname>Zriwil</surname> <given-names>A</given-names></name><name><surname>Lutteropp</surname> <given-names>M</given-names></name><name><surname>Grover</surname> <given-names>A</given-names></name><name><surname>Mead</surname> <given-names>A</given-names></name><name><surname>Sitnicka</surname> <given-names>E</given-names></name><name><surname>Jacobsen</surname> <given-names>SEW</given-names></name><name><surname>Nerlov</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Distinct myeloid progenitor-differentiation pathways identified through single-cell RNA sequencing</article-title><source>Nature Immunology</source><volume>17</volume><fpage>666</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1038/ni.3412</pub-id><pub-id pub-id-type="pmid">27043410</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dykstra</surname> <given-names>B</given-names></name><name><surname>Kent</surname> <given-names>D</given-names></name><name><surname>Bowie</surname> <given-names>M</given-names></name><name><surname>McCaffrey</surname> <given-names>L</given-names></name><name><surname>Hamilton</surname> <given-names>M</given-names></name><name><surname>Lyons</surname> <given-names>K</given-names></name><name><surname>Lee</surname> <given-names>SJ</given-names></name><name><surname>Brinkman</surname> <given-names>R</given-names></name><name><surname>Eaves</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Long-term propagation of distinct hematopoietic differentiation programs in vivo</article-title><source>Cell Stem Cell</source><volume>1</volume><fpage>218</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2007.05.015</pub-id><pub-id pub-id-type="pmid">18371352</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dzierzak</surname> <given-names>E</given-names></name><name><surname>Philipsen</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Erythropoiesis: development and differentiation</article-title><source>Cold Spring Harbor Perspectives in Medicine</source><volume>3</volume><elocation-id>a011601</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a011601</pub-id><pub-id pub-id-type="pmid">23545573</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galli</surname> <given-names>SJ</given-names></name><name><surname>Borregaard</surname> <given-names>N</given-names></name><name><surname>Wynn</surname> <given-names>TA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils</article-title><source>Nature Immunology</source><volume>12</volume><fpage>1035</fpage><lpage>1044</lpage><pub-id pub-id-type="doi">10.1038/ni.2109</pub-id><pub-id pub-id-type="pmid">22012443</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gazit</surname> <given-names>R</given-names></name><name><surname>Mandal</surname> <given-names>PK</given-names></name><name><surname>Ebina</surname> <given-names>W</given-names></name><name><surname>Ben-Zvi</surname> <given-names>A</given-names></name><name><surname>Nombela-Arrieta</surname> <given-names>C</given-names></name><name><surname>Silberstein</surname> <given-names>LE</given-names></name><name><surname>Rossi</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Fgd5 identifies hematopoietic stem cells in the murine bone marrow</article-title><source>The Journal of Experimental Medicine</source><volume>211</volume><fpage>1315</fpage><lpage>1331</lpage><pub-id pub-id-type="doi">10.1084/jem.20130428</pub-id><pub-id pub-id-type="pmid">24958848</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginhoux</surname> <given-names>F</given-names></name><name><surname>Guilliams</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Tissue-resident macrophage ontogeny and homeostasis</article-title><source>Immunity</source><volume>44</volume><fpage>439</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.02.024</pub-id><pub-id pub-id-type="pmid">26982352</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grzywacz</surname> <given-names>B</given-names></name><name><surname>Kataria</surname> <given-names>N</given-names></name><name><surname>Kataria</surname> <given-names>N</given-names></name><name><surname>Blazar</surname> <given-names>BR</given-names></name><name><surname>Miller</surname> <given-names>JS</given-names></name><name><surname>Verneris</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Natural killer-cell differentiation by myeloid progenitors</article-title><source>Blood</source><volume>117</volume><fpage>3548</fpage><lpage>3558</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-04-281394</pub-id><pub-id pub-id-type="pmid">21173117</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harker</surname> <given-names>LA</given-names></name><name><surname>Roskos</surname> <given-names>LK</given-names></name><name><surname>Marzec</surname> <given-names>UM</given-names></name><name><surname>Carter</surname> <given-names>RA</given-names></name><name><surname>Cherry</surname> <given-names>JK</given-names></name><name><surname>Sundell</surname> <given-names>B</given-names></name><name><surname>Cheung</surname> <given-names>EN</given-names></name><name><surname>Terry</surname> <given-names>D</given-names></name><name><surname>Sheridan</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers</article-title><source>Blood</source><volume>95</volume><fpage>2514</fpage><lpage>2522</lpage><pub-id pub-id-type="pmid">10753829</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Havran</surname> <given-names>WL</given-names></name><name><surname>Allison</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Origin of Thy-1+ dendritic epidermal cells of adult mice from fetal thymic precursors</article-title><source>Nature</source><volume>344</volume><fpage>68</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1038/344068a0</pub-id><pub-id pub-id-type="pmid">1968230</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayakawa</surname> <given-names>K</given-names></name><name><surname>Hardy</surname> <given-names>RR</given-names></name><name><surname>Herzenberg</surname> <given-names>LA</given-names></name><name><surname>Herzenberg</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Progenitors for Ly-1 B cells are distinct from progenitors for other B cells</article-title><source>Journal of Experimental Medicine</source><volume>161</volume><fpage>1554</fpage><lpage>1568</lpage><pub-id pub-id-type="doi">10.1084/jem.161.6.1554</pub-id><pub-id pub-id-type="pmid">3874257</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kantor</surname> <given-names>AB</given-names></name><name><surname>Stall</surname> <given-names>AM</given-names></name><name><surname>Adams</surname> <given-names>S</given-names></name><name><surname>Watanabe</surname> <given-names>K</given-names></name><name><surname>Herzenberg</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>De novo development and self-replenishment of B cells</article-title><source>International Immunology</source><volume>7</volume><fpage>55</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1093/intimm/7.1.55</pub-id><pub-id pub-id-type="pmid">7536467</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiel</surname> <given-names>MJ</given-names></name><name><surname>Yilmaz</surname> <given-names>OH</given-names></name><name><surname>Iwashita</surname> <given-names>T</given-names></name><name><surname>Yilmaz</surname> <given-names>OH</given-names></name><name><surname>Terhorst</surname> <given-names>C</given-names></name><name><surname>Morrison</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells</article-title><source>Cell</source><volume>121</volume><fpage>1109</fpage><lpage>1121</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.05.026</pub-id><pub-id pub-id-type="pmid">15989959</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiel</surname> <given-names>MJ</given-names></name><name><surname>Yilmaz</surname> <given-names>OH</given-names></name><name><surname>Morrison</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>CD150- cells are transiently reconstituting multipotent progenitors with little or no stem cell activity</article-title><source>Blood</source><volume>111</volume><fpage>4413</fpage><lpage>4414</lpage><pub-id pub-id-type="doi">10.1182/blood-2007-12-129601</pub-id><pub-id pub-id-type="pmid">18398056</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>R</given-names></name><name><surname>Neff</surname> <given-names>NF</given-names></name><name><surname>Quake</surname> <given-names>SR</given-names></name><name><surname>Weissman</surname> <given-names>IL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Tracking single hematopoietic stem cells in vivo using high-throughput sequencing in conjunction with viral genetic barcoding</article-title><source>Nature Biotechnology</source><volume>29</volume><fpage>928</fpage><lpage>933</lpage><pub-id pub-id-type="doi">10.1038/nbt.1977</pub-id><pub-id pub-id-type="pmid">21964413</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madisen</surname> <given-names>L</given-names></name><name><surname>Zwingman</surname> <given-names>TA</given-names></name><name><surname>Sunkin</surname> <given-names>SM</given-names></name><name><surname>Oh</surname> <given-names>SW</given-names></name><name><surname>Zariwala</surname> <given-names>HA</given-names></name><name><surname>Gu</surname> <given-names>H</given-names></name><name><surname>Ng</surname> <given-names>LL</given-names></name><name><surname>Palmiter</surname> <given-names>RD</given-names></name><name><surname>Hawrylycz</surname> <given-names>MJ</given-names></name><name><surname>Jones</surname> <given-names>AR</given-names></name><name><surname>Lein</surname> <given-names>ES</given-names></name><name><surname>Zeng</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A robust and high-throughput Cre reporting and characterization system for the whole mouse brain</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1038/nn.2467</pub-id><pub-id pub-id-type="pmid">20023653</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrison</surname> <given-names>SJ</given-names></name><name><surname>Wandycz</surname> <given-names>AM</given-names></name><name><surname>Akashi</surname> <given-names>K</given-names></name><name><surname>Globerson</surname> <given-names>A</given-names></name><name><surname>Weissman</surname> <given-names>IL</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>The aging of hematopoietic stem cells</article-title><source>Nature Medicine</source><volume>2</volume><fpage>1011</fpage><lpage>1016</lpage><pub-id pub-id-type="doi">10.1038/nm0996-1011</pub-id><pub-id pub-id-type="pmid">8782459</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oguro</surname> <given-names>H</given-names></name><name><surname>Ding</surname> <given-names>L</given-names></name><name><surname>Morrison</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>SLAM family markers resolve functionally distinct subpopulations of hematopoietic stem cells and multipotent progenitors</article-title><source>Cell Stem Cell</source><volume>13</volume><fpage>102</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2013.05.014</pub-id><pub-id pub-id-type="pmid">23827712</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palchaudhuri</surname> <given-names>R</given-names></name><name><surname>Saez</surname> <given-names>B</given-names></name><name><surname>Hoggatt</surname> <given-names>J</given-names></name><name><surname>Schajnovitz</surname> <given-names>A</given-names></name><name><surname>Sykes</surname> <given-names>DB</given-names></name><name><surname>Tate</surname> <given-names>TA</given-names></name><name><surname>Czechowicz</surname> <given-names>A</given-names></name><name><surname>Kfoury</surname> <given-names>Y</given-names></name><name><surname>Ruchika</surname> <given-names>F</given-names></name><name><surname>Rossi</surname> <given-names>DJ</given-names></name><name><surname>Verdine</surname> <given-names>GL</given-names></name><name><surname>Mansour</surname> <given-names>MK</given-names></name><name><surname>Scadden</surname> <given-names>DT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin</article-title><source>Nature Biotechnology</source><volume>34</volume><fpage>738</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1038/nbt.3584</pub-id><pub-id pub-id-type="pmid">27272386</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname> <given-names>F</given-names></name><name><surname>Arkin</surname> <given-names>Y</given-names></name><name><surname>Giladi</surname> <given-names>A</given-names></name><name><surname>Jaitin</surname> <given-names>DA</given-names></name><name><surname>Kenigsberg</surname> <given-names>E</given-names></name><name><surname>Keren-Shaul</surname> <given-names>H</given-names></name><name><surname>Winter</surname> <given-names>D</given-names></name><name><surname>Lara-Astiaso</surname> <given-names>D</given-names></name><name><surname>Gury</surname> <given-names>M</given-names></name><name><surname>Weiner</surname> <given-names>A</given-names></name><name><surname>David</surname> <given-names>E</given-names></name><name><surname>Cohen</surname> <given-names>N</given-names></name><name><surname>Lauridsen</surname> <given-names>FK</given-names></name><name><surname>Haas</surname> <given-names>S</given-names></name><name><surname>Schlitzer</surname> <given-names>A</given-names></name><name><surname>Mildner</surname> <given-names>A</given-names></name><name><surname>Ginhoux</surname> <given-names>F</given-names></name><name><surname>Jung</surname> <given-names>S</given-names></name><name><surname>Trumpp</surname> <given-names>A</given-names></name><name><surname>Porse</surname> <given-names>BT</given-names></name><name><surname>Tanay</surname> <given-names>A</given-names></name><name><surname>Amit</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Transcriptional Heterogeneity and Lineage Commitment in Myeloid Progenitors</article-title><source>Cell</source><volume>163</volume><fpage>1663</fpage><lpage>1677</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.11.013</pub-id><pub-id pub-id-type="pmid">26627738</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietras</surname> <given-names>EM</given-names></name><name><surname>Reynaud</surname> <given-names>D</given-names></name><name><surname>Kang</surname> <given-names>YA</given-names></name><name><surname>Carlin</surname> <given-names>D</given-names></name><name><surname>Calero-Nieto</surname> <given-names>FJ</given-names></name><name><surname>Leavitt</surname> <given-names>AD</given-names></name><name><surname>Stuart</surname> <given-names>JM</given-names></name><name><surname>Göttgens</surname> <given-names>B</given-names></name><name><surname>Passegué</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Functionally Distinct Subsets of Lineage-Biased Multipotent Progenitors Control Blood Production in Normal and Regenerative Conditions</article-title><source>Cell Stem Cell</source><volume>17</volume><fpage>35</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2015.05.003</pub-id><pub-id pub-id-type="pmid">26095048</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pronk</surname> <given-names>CJ</given-names></name><name><surname>Rossi</surname> <given-names>DJ</given-names></name><name><surname>Månsson</surname> <given-names>R</given-names></name><name><surname>Attema</surname> <given-names>JL</given-names></name><name><surname>Norddahl</surname> <given-names>GL</given-names></name><name><surname>Chan</surname> <given-names>CK</given-names></name><name><surname>Sigvardsson</surname> <given-names>M</given-names></name><name><surname>Weissman</surname> <given-names>IL</given-names></name><name><surname>Bryder</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy</article-title><source>Cell Stem Cell</source><volume>1</volume><fpage>428</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2007.07.005</pub-id><pub-id pub-id-type="pmid">18371379</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodvien</surname> <given-names>R</given-names></name><name><surname>Mielke</surname> <given-names>CH</given-names></name></person-group><year iso-8601-date="1976">1976</year><article-title>Role of platelets in hemostasis and thrombosis</article-title><source>The Western Journal of Medicine</source><volume>125</volume><fpage>181</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">969503</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname> <given-names>DJ</given-names></name><name><surname>Bryder</surname> <given-names>D</given-names></name><name><surname>Zahn</surname> <given-names>JM</given-names></name><name><surname>Ahlenius</surname> <given-names>H</given-names></name><name><surname>Sonu</surname> <given-names>R</given-names></name><name><surname>Wagers</surname> <given-names>AJ</given-names></name><name><surname>Weissman</surname> <given-names>IL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Cell intrinsic alterations underlie hematopoietic stem cell aging</article-title><source>PNAS</source><volume>102</volume><fpage>9194</fpage><lpage>9199</lpage><pub-id pub-id-type="doi">10.1073/pnas.0503280102</pub-id><pub-id pub-id-type="pmid">15967997</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rundberg Nilsson</surname> <given-names>A</given-names></name><name><surname>Pronk</surname> <given-names>CJ</given-names></name><name><surname>Bryder</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Probing hematopoietic stem cell function using serial transplantation: Seeding characteristics and the impact of stem cell purification</article-title><source>Experimental Hematology</source><volume>43</volume><fpage>812</fpage><lpage>817</lpage><pub-id pub-id-type="doi">10.1016/j.exphem.2015.05.003</pub-id><pub-id pub-id-type="pmid">26027791</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanjuan-Pla</surname> <given-names>A</given-names></name><name><surname>Macaulay</surname> <given-names>IC</given-names></name><name><surname>Jensen</surname> <given-names>CT</given-names></name><name><surname>Woll</surname> <given-names>PS</given-names></name><name><surname>Luis</surname> <given-names>TC</given-names></name><name><surname>Mead</surname> <given-names>A</given-names></name><name><surname>Moore</surname> <given-names>S</given-names></name><name><surname>Carella</surname> <given-names>C</given-names></name><name><surname>Matsuoka</surname> <given-names>S</given-names></name><name><surname>Bouriez Jones</surname> <given-names>T</given-names></name><name><surname>Chowdhury</surname> <given-names>O</given-names></name><name><surname>Stenson</surname> <given-names>L</given-names></name><name><surname>Lutteropp</surname> <given-names>M</given-names></name><name><surname>Green</surname> <given-names>JC</given-names></name><name><surname>Facchini</surname> <given-names>R</given-names></name><name><surname>Boukarabila</surname> <given-names>H</given-names></name><name><surname>Grover</surname> <given-names>A</given-names></name><name><surname>Gambardella</surname> <given-names>A</given-names></name><name><surname>Thongjuea</surname> <given-names>S</given-names></name><name><surname>Carrelha</surname> <given-names>J</given-names></name><name><surname>Tarrant</surname> <given-names>P</given-names></name><name><surname>Atkinson</surname> <given-names>D</given-names></name><name><surname>Clark</surname> <given-names>SA</given-names></name><name><surname>Nerlov</surname> <given-names>C</given-names></name><name><surname>Jacobsen</surname> <given-names>SE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy</article-title><source>Nature</source><volume>502</volume><fpage>232</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1038/nature12495</pub-id><pub-id pub-id-type="pmid">23934107</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawai</surname> <given-names>CM</given-names></name><name><surname>Babovic</surname> <given-names>S</given-names></name><name><surname>Upadhaya</surname> <given-names>S</given-names></name><name><surname>Knapp</surname> <given-names>D</given-names></name><name><surname>Lavin</surname> <given-names>Y</given-names></name><name><surname>Lau</surname> <given-names>CM</given-names></name><name><surname>Goloborodko</surname> <given-names>A</given-names></name><name><surname>Feng</surname> <given-names>J</given-names></name><name><surname>Fujisaki</surname> <given-names>J</given-names></name><name><surname>Ding</surname> <given-names>L</given-names></name><name><surname>Mirny</surname> <given-names>LA</given-names></name><name><surname>Merad</surname> <given-names>M</given-names></name><name><surname>Eaves</surname> <given-names>CJ</given-names></name><name><surname>Reizis</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hematopoietic stem cells are the major source of multilineage hematopoiesis in adult animals</article-title><source>Immunity</source><volume>45</volume><fpage>597</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.08.007</pub-id><pub-id pub-id-type="pmid">27590115</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Säwén</surname> <given-names>P</given-names></name><name><surname>Lang</surname> <given-names>S</given-names></name><name><surname>Mandal</surname> <given-names>P</given-names></name><name><surname>Rossi</surname> <given-names>DJ</given-names></name><name><surname>Soneji</surname> <given-names>S</given-names></name><name><surname>Bryder</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mitotic history reveals distinct stem cell populations and their contributions to hematopoiesis</article-title><source>Cell Reports</source><volume>14</volume><fpage>2809</fpage><lpage>2818</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.02.073</pub-id><pub-id pub-id-type="pmid">26997272</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname> <given-names>JY</given-names></name><name><surname>Hu</surname> <given-names>W</given-names></name><name><surname>Naramura</surname> <given-names>M</given-names></name><name><surname>Park</surname> <given-names>CY</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>High c-Kit expression identifies hematopoietic stem cells with impaired self-renewal and megakaryocytic bias</article-title><source>The Journal of Experimental Medicine</source><volume>211</volume><fpage>217</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1084/jem.20131128</pub-id><pub-id pub-id-type="pmid">24446491</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siminovitch</surname> <given-names>L</given-names></name><name><surname>McCulloch</surname> <given-names>EA</given-names></name><name><surname>Till</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="1963">1963</year><article-title>The distribution of colony-forming cells among spleen colonies</article-title><source>Journal of Cellular and Comparative Physiology</source><volume>62</volume><fpage>327</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1002/jcp.1030620313</pub-id><pub-id pub-id-type="pmid">14086156</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudo</surname> <given-names>K</given-names></name><name><surname>Ema</surname> <given-names>H</given-names></name><name><surname>Morita</surname> <given-names>Y</given-names></name><name><surname>Nakauchi</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Age-associated characteristics of murine hematopoietic stem cells</article-title><source>The Journal of Experimental Medicine</source><volume>192</volume><fpage>1273</fpage><lpage>1280</lpage><pub-id pub-id-type="doi">10.1084/jem.192.9.1273</pub-id><pub-id pub-id-type="pmid">11067876</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>J</given-names></name><name><surname>Ramos</surname> <given-names>A</given-names></name><name><surname>Chapman</surname> <given-names>B</given-names></name><name><surname>Johnnidis</surname> <given-names>JB</given-names></name><name><surname>Le</surname> <given-names>L</given-names></name><name><surname>Ho</surname> <given-names>YJ</given-names></name><name><surname>Klein</surname> <given-names>A</given-names></name><name><surname>Hofmann</surname> <given-names>O</given-names></name><name><surname>Camargo</surname> <given-names>FD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Clonal dynamics of native haematopoiesis</article-title><source>Nature</source><volume>514</volume><fpage>322</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1038/nature13824</pub-id><pub-id pub-id-type="pmid">25296256</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Till</surname> <given-names>JE</given-names></name><name><surname>McCulloch</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="1961">1961</year><article-title>A direct measurement of the radiation sensitivity of normal mouse bone marrow cells</article-title><source>Radiation Research</source><volume>14</volume><fpage>213</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.2307/3570892</pub-id><pub-id pub-id-type="pmid">13776896</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ugale</surname> <given-names>A</given-names></name><name><surname>Norddahl</surname> <given-names>GL</given-names></name><name><surname>Wahlestedt</surname> <given-names>M</given-names></name><name><surname>Säwén</surname> <given-names>P</given-names></name><name><surname>Jaako</surname> <given-names>P</given-names></name><name><surname>Pronk</surname> <given-names>CJ</given-names></name><name><surname>Soneji</surname> <given-names>S</given-names></name><name><surname>Cammenga</surname> <given-names>J</given-names></name><name><surname>Bryder</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Hematopoietic stem cells are intrinsically protected against MLL-ENL-mediated transformation</article-title><source>Cell Reports</source><volume>9</volume><fpage>1246</fpage><lpage>1255</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.10.036</pub-id><pub-id pub-id-type="pmid">25456127</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Putten</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="1958">1958</year><article-title>The life span of red cells in the rat and the mouse as determined by labeling with DFP32 in vivo</article-title><source>Blood</source><volume>13</volume><fpage>789</fpage><lpage>794</lpage><pub-id pub-id-type="pmid">13560578</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velten</surname> <given-names>L</given-names></name><name><surname>Haas</surname> <given-names>SF</given-names></name><name><surname>Raffel</surname> <given-names>S</given-names></name><name><surname>Blaszkiewicz</surname> <given-names>S</given-names></name><name><surname>Islam</surname> <given-names>S</given-names></name><name><surname>Hennig</surname> <given-names>BP</given-names></name><name><surname>Hirche</surname> <given-names>C</given-names></name><name><surname>Lutz</surname> <given-names>C</given-names></name><name><surname>Buss</surname> <given-names>EC</given-names></name><name><surname>Nowak</surname> <given-names>D</given-names></name><name><surname>Boch</surname> <given-names>T</given-names></name><name><surname>Hofmann</surname> <given-names>WK</given-names></name><name><surname>Ho</surname> <given-names>AD</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Trumpp</surname> <given-names>A</given-names></name><name><surname>Essers</surname> <given-names>MA</given-names></name><name><surname>Steinmetz</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Human haematopoietic stem cell lineage commitment is a continuous process</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>271</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1038/ncb3493</pub-id><pub-id pub-id-type="pmid">28319093</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weksberg</surname> <given-names>DC</given-names></name><name><surname>Chambers</surname> <given-names>SM</given-names></name><name><surname>Boles</surname> <given-names>NC</given-names></name><name><surname>Goodell</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>CD150- side population cells represent a functionally distinct population of long-term hematopoietic stem cells</article-title><source>Blood</source><volume>111</volume><fpage>2444</fpage><lpage>2451</lpage><pub-id pub-id-type="doi">10.1182/blood-2007-09-115006</pub-id><pub-id pub-id-type="pmid">18055867</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westera</surname> <given-names>L</given-names></name><name><surname>Drylewicz</surname> <given-names>J</given-names></name><name><surname>den Braber</surname> <given-names>I</given-names></name><name><surname>Mugwagwa</surname> <given-names>T</given-names></name><name><surname>van der Maas</surname> <given-names>I</given-names></name><name><surname>Kwast</surname> <given-names>L</given-names></name><name><surname>Volman</surname> <given-names>T</given-names></name><name><surname>van de Weg-Schrijver</surname> <given-names>EH</given-names></name><name><surname>Bartha</surname> <given-names>I</given-names></name><name><surname>Spierenburg</surname> <given-names>G</given-names></name><name><surname>Gaiser</surname> <given-names>K</given-names></name><name><surname>Ackermans</surname> <given-names>MT</given-names></name><name><surname>Asquith</surname> <given-names>B</given-names></name><name><surname>de Boer</surname> <given-names>RJ</given-names></name><name><surname>Tesselaar</surname> <given-names>K</given-names></name><name><surname>Borghans</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans</article-title><source>Blood</source><volume>122</volume><fpage>2205</fpage><lpage>2212</lpage><pub-id pub-id-type="doi">10.1182/blood-2013-03-488411</pub-id><pub-id pub-id-type="pmid">23945154</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>A</given-names></name><name><surname>Laurenti</surname> <given-names>E</given-names></name><name><surname>Oser</surname> <given-names>G</given-names></name><name><surname>van der Wath</surname> <given-names>RC</given-names></name><name><surname>Blanco-Bose</surname> <given-names>W</given-names></name><name><surname>Jaworski</surname> <given-names>M</given-names></name><name><surname>Offner</surname> <given-names>S</given-names></name><name><surname>Dunant</surname> <given-names>CF</given-names></name><name><surname>Eshkind</surname> <given-names>L</given-names></name><name><surname>Bockamp</surname> <given-names>E</given-names></name><name><surname>Lió</surname> <given-names>P</given-names></name><name><surname>Macdonald</surname> <given-names>HR</given-names></name><name><surname>Trumpp</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair</article-title><source>Cell</source><volume>135</volume><fpage>1118</fpage><lpage>1129</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.10.048</pub-id><pub-id pub-id-type="pmid">19062086</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>C</given-names></name><name><surname>Li</surname> <given-names>B</given-names></name><name><surname>Lu</surname> <given-names>R</given-names></name><name><surname>Koelle</surname> <given-names>SJ</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Jares</surname> <given-names>A</given-names></name><name><surname>Krouse</surname> <given-names>AE</given-names></name><name><surname>Metzger</surname> <given-names>M</given-names></name><name><surname>Liang</surname> <given-names>F</given-names></name><name><surname>Loré</surname> <given-names>K</given-names></name><name><surname>Wu</surname> <given-names>CO</given-names></name><name><surname>Donahue</surname> <given-names>RE</given-names></name><name><surname>Chen</surname> <given-names>ISY</given-names></name><name><surname>Weissman</surname> <given-names>I</given-names></name><name><surname>Dunbar</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells</article-title><source>Cell Stem Cell</source><volume>14</volume><fpage>486</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2014.01.020</pub-id><pub-id pub-id-type="pmid">24702997</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.41258.017</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Majeti</surname><given-names>Ravindra</given-names></name><role>Reviewing Editor</role><aff><institution>Stanford University</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;HSCs contribute actively to native multilineage hematopoiesis but with reduced differentiation capacity upon aging&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by two peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Sean Morrison as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>The manuscript by Säwén et al. uses an HSC-specific Fgd5 reporter mouse strain to investigate steady state mouse hematopoiesis. Using this method, the authors demonstrate that HSCs continuously give rise to multilineage hematopoiesis, with kinetics increasing from platelets, to erythrocytes, granulocytes, NK cells, B cells, and T cells. They also provide evidence that these mature cells are derived from intermediate progenitor cells that are the progeny of HSCs. Moreover, they corroborate recent studies demonstrating that a subset of hematopoietic cells including B1 B cells, Langerhans cells, and microglia are not derived from adult HSCs, but arise during fetal hematopoiesis. Finally, they show that HSC contribution to multilineage hematopoiesis declines with aging. These results are consistent with the classical model of hematopoiesis in which HSCs continuously give rise to multi-lineage hematopoiesis through intermediate lineage-restricted progenitors and contrast with several recent reports challenging this model. The observation that the contribution to hematopoiesis declines with age is very interesting.</p><p>1) The authors highlight the recent publications on steady state mouse hematopoiesis by Sun et al. and Busch et al. which suggest that HSCs do not contribute significantly to multilineage blood production and that there can be long-term lineage restricted progenitors. The current results are in contrast to these other reports and the manuscript should highlight this distinction more clearly in the Abstract and Discussion.</p><p>2) It is a little surprising that the percentage of Tomato<sup>+</sup> progenitors is not higher even after 28 weeks post-induction in MPPs as well as other committed progenitors. This phenomenon could be due to only a subset of HSCs differentiating at any given time, as has been suggested by others such as Camargo, but it also raises the possibility that the Tomato protein somehow alters HPSC function. Indeed, there is such a suggestion of this in Figure 1F in the long-term reconstitution experiments since grafts from Tomato positive and negative HSCs do not appear the same with respect to% reconstitution (or possibly even lineage composition). In order to show that Tomato does not cause problems with differentiation, the authors should show that the lineage potential and total cell output does not differ between Tomato<sup>+</sup> and negative HSCs and sorted progenitors. Such studies can be performed in differentiation/reconstitution assays in vitro or in vivo, and ideally this should be performed using HSCs from multiple independent donor mice. Related to this point, how many independent donors were used in Figure 1F? It seems that at least 3 independent donors (biological replicates) would be required to answer the question of whether or not there are differences in the reconstitution potential or lineage potential of Tomato<sup>+</sup> and Tomato<sup>-</sup> HSCs.</p><p>3) Although the delayed contribution of old HSCs to MPPs is not surprising given that they are known to cycle slower than young HSCs, these experiments are only reliable if the Fgd5 reporter system works the same way in old HSCs as young; it does not appear the authors have confirmed this. In order to demonstrate this, the authors should show that Fgd5 expression is limited to HSCs in old mice and evaluate the distribution of Tomato labelling in the various types of HSCs (immunophenotypically defined My-bi, Balanced, Ly-bi) in old compared to young mice.</p><p>4) The authors conclude their studies indicate that adult HSCs do not contribute significantly to several lineages (e.g. microglial cells, Langerhans cells), and they therefore conclude that such cells arise from fetal HSCs. It is not clear from the Materials and methods exactly when the HSCs were induced to express Tomato, but it is likely in mice &lt;8-10 weeks. Thus, while this speculation certainly is not unreasonable, at the same time these experiments were not designed in such a way to completely exclude this possibility. The authors are encouraged to be more circumspect with respect to the timing of the induction when making statements about whether or not post-natal HSCs may give rise to these cell populations. The Results and Discussion sections should be adjusted accordingly to mention this limitation of the studies.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.41258.018</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>[…] 1) The authors highlight the recent publications on steady state mouse hematopoiesis by Sun et al. and Busch et al. which suggest that HSCs do not contribute significantly to multilineage blood production and that there can be long-term lineage restricted progenitors. The current results are in contrast to these other reports and the manuscript should highlight this distinction more clearly in the Abstract and Discussion.</p></disp-quote><p>We have changed the wording in both the Abstract and Discussion to more directly emphasize our quite different conclusions compared to those of Sun et al. and Busch et al.</p><disp-quote content-type="editor-comment"><p>2) It is a little surprising that the percentage of Tomato<sup>+</sup> progenitors is not higher even after 28 weeks post-induction in MPPs as well as other committed progenitors. This phenomenon could be due to only a subset of HSCs differentiating at any given time, as has been suggested by others such as Camargo, but it also raises the possibility that the Tomato protein somehow alters HPSC function. Indeed, there is such a suggestion of this in Figure 1F in the long-term reconstitution experiments since grafts from Tomato positive and negative HSCs do not appear the same with respect to% reconstitution (or possibly even lineage composition).</p><p>In order to show that Tomato does not cause problems with differentiation, the authors should show that the lineage potential and total cell output does not differ between Tomato<sup>+</sup> and negative HSCs and sorted progenitors. Such studies can be performed in differentiation/reconstitution assays in vitro or in vivo, and ideally this should be performed using HSCs from multiple independent donor mice. Related to this point, how many independent donors were used in Figure 1F? It seems that at least 3 independent donors (biological replicates) would be required to answer the question of whether or not there are differences in the reconstitution potential or lineage potential of Tomato<sup>+</sup> and Tomato<sup>-</sup> HSCs.</p></disp-quote><p>This is an insightful comment and we agree that the kinetic of replenishment of some multipotent progenitor subsets (especially GMLPs) is surprisingly slow. We interpret/discuss that this should reflect that some progenitors are imbued with a rather extensive self-renewal capability. A slow input to progenitor compartments from HSCs is also consistent with the preferential Tomato labeling of the least active HSCs by one Tamoxifen injection (Figure 1E).</p><p>While we don’t believe that the Tomato protein per se alters HSPC function (see <xref ref-type="fig" rid="respfig1">Author response image 1</xref>), we however acknowledge that <italic>Fgd5<sup>CreERT2/+</sup></italic> preferentially labels primitive/dormant HSCs after administration of lower doses of Tamoxifen. This is likely a consequence of higher Fgd5 expression in the most primitive HSCs (Säwén et al., 2016). We illustrate this in Figure 1E in our manuscript, which demonstrates preferential Tomato labeling by <italic>Fgd5<sup>CreERT2/+</sup></italic> of the most H2B-label retaining HSCs. We consider dormancy/quiescence as a hallmark property of HSCs with the highest reconstitution potential, a view supported by a large number of previous studies. In light of this, we do not think it is surprising that Tomato<sup>+</sup> HSCs could have somewhat different reconstitution patterns than Tomato negative HSCs (Figure 1F).</p><p>In an attempt to make a more fair comparison, we have compared the behavior of Tomato<sup>+</sup> HSCs (in Figure 1F) to LSK-SLAM HSCs with a more restricted proliferation history (Säwén et al., 2016) following transplantation. This revealed a highly similar lineage distribution from Tomato<sup>+</sup> HSCs and Tomato<sup>-</sup> HSCs (see <xref ref-type="fig" rid="respfig1">Author response image 1</xref>). One potential concern of this comparison is however the limited number of cells transplanted (5 cells and 10 cells, respectively, with rather limited numbers of mice/group). We therefore also compared the behavior of Tomato<sup>+</sup> donor cells following reconstitution with 200 <italic>Fgd5<sup>CreERT2</sup></italic> x Tomato HSCs (from Figure 4C in our manuscript) to a previous experiment in which we evaluated 100 HSCs isolated solely based on phenotype from WT mice (Supplementary information in Ugale et al., 2014). Also in this comparison, we observed no significant differences (2-tailed Student’s t-test) in lineage reconstitution between Tomato<sup>+</sup> and Tomato<sup>-</sup> HSCs. Collectively, we have therefore little reason to suspect altered cellular function caused by Tomato protein expression per se.</p><fig id="respfig1"><label>Author response image 1.</label><caption><title>The Tomato fluorescent protein does not influence on the in vivo differentiation potential of HSCs.</title></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-41258-resp-fig1-v1"/></fig><disp-quote content-type="editor-comment"><p>3) Although the delayed contribution of old HSCs to MPPs is not surprising given that they are known to cycle slower than young HSCs, these experiments are only reliable if the Fgd5 reporter system works the same way in old HSCs as young; it does not appear the authors have confirmed this. In order to demonstrate this, the authors should show that Fgd5 expression is limited to HSCs in old mice and evaluate the distribution of Tomato labelling in the various types of HSCs (immunophenotypically defined My-bi, Balanced, Ly-bi) in old compared to young mice.</p></disp-quote><p>This is of course a highly relevant comment as a differential expression of Fgd5 in old animals could underlie our findings. We note that we in our original manuscript provided limited information on this. We began to address the HSCs specificity of the <italic>Fgd5<sup>CreERT2/+</sup></italic> system in aged animals in Figure 4A, where we investigated the Tomato labeling of HSPCs after 5 daily tamoxifen injections. This showed that among LSK cells, virtually all Tomato<sup>+</sup> cells are HSCs (or perhaps more accurately phrased, have an HSC phenotype) in old animals.</p><p>In addition to CreERT2, the mouse strain we work with also express a ZsGreen fluorescent reporter protein from the Fgd5-locus (Figure 2B). We have now taken advantage of this and compared Fgd5-ZsGreen expression in young and old mice (see <xref ref-type="fig" rid="respfig2">Author response image 2</xref>). This revealed the highest Fgd5 expression in the CD150 highest HSCs (previously suggested to be myeloid-biased) both in young (8 weeks old) and aged (96 weeks old) mice, but also substantial expression of Fgd5 in CD150 intermediate HSCs (“Balanced”; in both young and old mice). A much more limited expression of Fgd5 is observed in CD150 negative candidate HSCs (Ly-bi). Compared to our previous work in which we defined HSC subtypes based on levels of CD150 (Beerman et al., 2010), we could here not include selection based on CD34-negativity (both because of technical incompatibilities but above all the well-established fact that levels of CD34 on HSCs fluctuate with activation). Not selecting for CD34-negativity likely underlies the differences in frequencies of these subsets in young/old mice (especially the larger fraction of CD150 negative cells) compared to our previous work (Beerman et al., 2010).</p><fig id="respfig2"><label>Author response image 2.</label><caption><title>The expression of Fgd5 in HSC subsets of young and old mice.</title></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-41258-resp-fig2-v1"/></fig><disp-quote content-type="editor-comment"><p>4) The authors conclude their studies indicate that adult HSCs do not contribute significantly to several lineages (e.g. microglial cells, Langerhans cells), and they therefore conclude that such cells arise from fetal HSCs. It is not clear from the Materials and methods exactly when the HSCs were induced to express Tomato, but it is likely in mice &lt;8-10 weeks. Thus, while this speculation certainly is not unreasonable, at the same time these experiments were not designed in such a way to completely exclude this possibility. The authors are encouraged to be more circumspect with respect to the timing of the induction when making statements about whether or not post-natal HSCs may give rise to these cell populations. The Results and Discussion sections should be adjusted accordingly to mention this limitation of the studies.</p></disp-quote><p>We thank the reviewers for this comment and completely agree that our original wording was inappropriate. Accordingly, we have made changes to the Results and Discussion:</p><p>Subsection title changed to “Fgd5-mediated HSC lineage tracing corroborates the fetal/juvenile origin of Langerhans cells, B1a B cells and brain microglial cells”.</p><p>Subsection “Fgd5-mediated HSC lineage tracing corroborates the fetal/juvenile origin of Langerhans cells, B1a B cells and brain microglial cells”: “This is in line with a more strict fetal/postnatal origin of B1a B cells.”</p><p>Discussion section: “Our work revealed robust HSC contribution to adult multilineage hematopoiesis and, while not focused at studying fetal hematopoiesis, support the previously reported fetal/juvenile origins of several other specific hematopoietic subsets.”</p><p>References:</p><p>Beerman I., Battacharya D., Zandi S., Sigvardsson M., Weissman I.L., Bryder D., Rossi D.J. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. <italic>PNAS</italic> March 23, 2010 107 (12) 5465-5470; https://doi.org/10.1073/pnas.1000834107</p></body></sub-article></article>